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 The extracellular matrix provides physical support and functional 
microenvironment in which cells exist for healthy tissue formation and maintenance. This 
dynamic interplay between the extracellular matrix and cells have significant effect on 
cellular functions like cell adhesion, cell proliferation and cell differentiation. To mimic 
this multimolecular three-dimension network during tissue damage, like disease, trauma 
or functional failure, tissue engineering introduces us to apply the principles of material 
science and life science for developing biocompatible materials.  
 According to 2019 United Network for Organ Sharing report 3,180 transplants 
were performed with 113,839 people still on the waiting list. The sole reliance on 
transplantation has not only created a waiting list but also a rise in the health care cost. 
Current strategies involve the use of donated organs or tissues either from one patient to 
another or from one part of the patient’s body to another part of the body in the same 
patient. These practices have limitations like immunogenic rejection, risk of disease 
transmission, costly immunosuppression therapies and difficult and time-consuming 
surgical procedures. Therefore, there is a growing need for modifying factors like 
biomaterials that act as scaffold matrices and serve as a platform for the cells to grow and 
form tissues upon transplantation. In this study, we have utilized a biomimetic approach 
to produce a material that acts as a bioscaffold while examining its properties for its 
application in the field of bone tissue engineering.  
 Bacterial cellulose is a polysaccharide material that is synthesized by specific 
types of bacteria like Acetobacter, Azotobacter, Gluconacetobacter, Pseudomonas, 
Salmonella and Sarcina ventriculi. Among them the most effective are 
Gluconacetobacter xylinum, Gluconacetobacter hansenii, and Gluconacetobacter 
pasteurianus. These bacteria polymerize glucose residues into linear β-1,4-glucan chains 
that assemble and crystallize cellulose ribbons. These ribbons form a three-dimensional 
network of cellulose nanofibers with ideal properties like hydrophilicity, high surface 
area, excellent mechanical property, moldability and high purity as compared to plant 
cellulose. In this work, we have fermented bacterial cellulose using Gluconacetobacter 
Hansenii that produces a pellicle of cellulose with similar properties. Human-derived 
placental mesenchymal stem cells were cultured on bacterial cellulose to study its 
osteogenic differentiation potential to function as a cell-scaffold construct for bone 
regeneration.  
 Our study found novel advances that enable bacterial cellulose to support the 
growth and differentiation of human-derived placental mesenchymal stem cell in vitro. 
Material characterization showed that bacterial cellulose has a fiber diameter of 40-60nm 
with twisted and interwoven cellulose fibrils caused due to the rotation of bacteria during 
fermentation. In its never-dried state the material is flexible and has a high stiffness while 
being brittle upon drying. The nanoscale feature of bacterial cellulose supported the 
growth of placental stem cells and showed no toxicity upon culturing for long hours. 
Further, the hydrophilic nature of bacterial cellulose enabled the differentiation of 
placental stem cells with high expression of early osteogenic marker like alkaline 
phosphatase and an increase in mineralized matrix by the end of 28 days. We have 
established the importance of hydrophilicity, nanotopography and material structure that 
showed improved biomineralization during osteogenic differentiation. This study 
provides a strong basis that material properties play a vital role in supporting the growth 
of the cells and its ability to deposit tissue-specific extracellular matrix. In this study, 
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 The growing tendency of age-related diseases that causes tissue damage or failure 
introduces us to the field of tissue engineering and regenerative medicine technology [1]. 
In general, autografts have been considered as the gold standard for treating tissue defects 
yet possesses limitations like risk of donor-site morbidity and the need of a second 
surgery [2]. The other traditional strategies like allograft, xenograft and metal implants 
have added disadvantages like rejection by the patient’s body, risk of pathogen 
transmitted to the recipient’s body, non-degradability and lack of integration into the host 
tissue [3]. To overcome the complications caused by the traditional methods, the field of 
tissue engineering has been growing continuously for the past ten years by combining 
research using stem cells, nanotechnology and biofunctional scaffold materials [4]. In this 
review, we will discuss the basic principles of tissue engineering that combines cell 
therapy and the application of different types of biomaterials for tissue repair and 
regeneration. 
1.2. Cell Therapies 
 Stem cells have been widely used for the continual maintenance of the tissues 
because of their unique properties like self-renewal and ability to differentiate into 
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different cell types [5]. Stem cells mediates diverse roles in the process of tissue repair 
and treat disease progression and development [6]. Stem cells can be classified into 
different types like embryonic stem cells (ESCs), tissue specific progenitor stem cells 
(TSPSCs), mesenchymal stem cells (MSCs), umbilical cord stem cells (UCSCs), bone 
marrow stem cells (BMSCs), and induced pluripotent stem cells (iPSCs). The 
applications of each stem cells in the field of tissue engineering and regenerative  
medicine technology are listed in the table (TABLE 1) below [6] [1] : 
 
 
Table 1. Stem Cell Therapies 
Stem Cell Types Promising Applications 
Embryonic stem cells  Cartilage lesion treatment 
 Heal heart defects 
 Treating spinal cord injury 
 Cartilage tissue engineering 
Tissue specific progenitor stem cells  Muscle regeneration 
 Neurodental applications 
 Cancer treatment 
Mesenchymal stem cells  Wound healing 
 Treating muscle injuries 
 Treating orthopedic injuries 
 Cardiovascular diseases 
 Cartilage tissue engineering 
Umbilical cord stem cells  Treating autoimmune disease 
 Nervous system diseases 
Bone marrow stem cells  Nerve tissue engineering 
 Alveolar bone regeneration 
 Regeneration of diaphragm tissue 
Induced pluripotent stem cells  Treating placental defects 
 Treating lung and liver disease 
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 Among the different types of stem cells listed above, mesenchymal stem cells 
have been used for its properties to differentiate into osteoblasts for this study. In general, 
mesenchymal stem cells have shown to demonstrate immunoregulatory role due to 
specific surface markers that separate them from other undifferentiated cell and 
encourage them for its utilization for transplantation studies [7, 8].  
1.3. Mesenchymal Stem Cells 
 The isolation of human mesenchymal stem cells was first performed using bone 
marrow with continuous progress achieved in insolating from various tissues like adipose 
tissue, peripheral blood, umbilical cord blood, amniotic cord membrane, etc. [7]. 
Mesenchymal stem cells are self-renewal and can be differentiated to multiple lineages 
like bone, cartilage, neuronal, adipose and stromal cells[8]. Mesenchymal stem cells are 
undifferentiated non-hematopoietic multipotent stromal cells that can regenerate injured 
or inflamed tissues in the body [9, 10]. They are described as multipotent because of their 
ability to act as a reservoir of reparative cells that lack tissue specific features [9]. 
Interesting properties of mesenchymal stem cells are that they can transdifferentiate 
(process by which cells differentiating to a specific lineage change their course and 
differentiate to other cell types due to genetic reprogramming) as well as dedifferentiate 
to its primitive stem-cell like stage when subjected to the right culture conditions [11]. 
The developing regenerative technologies have widely used mesenchymal stem cells for 
tissue repair as well as for therapeutic therapies. Maged et al., used mesenchymal stem 
cells for wound healing using chitosan scaffolds loaded with rosuvastatin and proved the 
potential of using stem-cell loaded scaffold in skin healing and regeneration [12]. Z.lei et 
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al., bone-marrow derived mesenchymal stem cells for its multi-directional differentiation 
potential and low immunogenicity. The study showed mesenchymal stem cells-
thermosensitive hydrogel improvement in wound closure of adult mouse model, 
epithelial cell proliferation and encouraged tissue remodeling after wound healing[13]. 
To treat degeneration of articular cartilage leading to osteoarthritis F.Li et al., used 
mesenchymal stem cells for its promising role in cartilage regeneration and chondrogenic 
differentiation potential. The injectable microgels loaded with human bone marrow-
derived mesenchymal stem cells tested positive for cartilage features using Alcian blue 
and Safranin O while showing distribution of type-II collagen and higher expression of 
early chondrogenic transcription factor Sox-9 confirming the differentiation of 
mesenchymal stem cells [14]. Schwann cells (SC) have been the promising seed cells for 
nerve tissue engineering, but due to expensive extraction method and inefficient cell 
production, M.Pan et al., explored the potential of induced peripheral-blood derived 
MSCs (iPBMSCs) to Schwann cells to repair injured peripheral nerves. The study 
showed that the iPBMSCs could be induced towards Schwann cells and survive into 
crushed injured sciatic nerve after transplantation in a rat model. They also found that the 
iPBMSCs served as a novel potential for nerve tissue engineering when seeded intro 
artificial nerve conduit in the sciatic nerve defect model [15]. For the application towards 
bone tissue engineering, Zhang et el., studied bone marrow-derived mesenchymal stem 
cells for osteogenic differentiation. While, the focus was on the 3D scaffold for bone 
regeneration, the study also showed that mesenchymal stem cells differentiated into 
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osteogenic lineage from alkaline phosphatase activity and gene expression studies with 
and without bone morphogenetic protein 2 (BMP-2) [16].  
 While stem cells alone have been widely used to treat an injury or disease by 
direct transplantation at the site of repair, it is important to make an artificial extracellular 
matrix (ECM) environment for the cells using biomaterials. This not only increases the 
chances of survival of the cells but also helps in supplying essential components to the 
cells during the process of tissue regeneration [1].  
1.4. Biomaterials in Tissue Engineering 
 With the increasing limitation in the availability of human donors, risk of 
rejection by the patient’s body, risk of infection due to organ transplant and poor long-
term outcome due to synthetic implants the advent of biomaterials in the tissue 
engineering has been considered as an innovative solution for promoting structural and 
functional regeneration to restore the affected tissue [7].  
 Biomaterials are an integral component of tissue engineering that integrate well 
with the adjacent host tissue with an aim to replace damaged or missing tissue [17]. The 
growing tendency of increased life expectancy has created the need to apply the 
principles of cell transplantation and biomaterial to create constructs that can mimic the 
ECM, thereby guiding the formation of new tissues [18]. While the earlier need of 
biomaterial to match the mechanical and material properties with the native tissue was 
important [17], the current parameters have widely changed to focus on regeneration 
capabilities of the tissue.  
 An ideal biomaterial should have the following characteristics [19]: 
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 Possess biomimetic structure that covers multiple hierarchical regimes (from the 
nanoscale to the macroscale) thus resembling tissue structure. 
 Control and regulate basic cellular functions such as adhesion and proliferation. 
 Workable, having the ability to alter its form to fabricate desirable shapes and  
 Controllable mechanical stability i.e. maintains its shape during new tissue 
formation but can if necessary be removed or degraded. 
 The material should be cost-effective,  
 Non-toxic for its translation to clinical setting 
 The material should be easily produced without addressing material complexity 
 There are several types of biomaterials used in tissue engineering like natural 
materials and synthetic materials. The TABLE 2 AND 3 summarizes the application of 
different biomaterials to serve as a template for regeneration of varied tissue types that 
have been currently studied in the literature.
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1.4.1. The Right Choice of Biomaterials 
 Extracellular matrix (ECM) is a natural template found in living organism. They 
are composed of structural proteins, cell adhesion proteins and glycans [17]. The 
functions supported by the ECM include [54, 55]: 
 First, structural and functional support to the cells: Extracellular matrix consists of 
fibers and ground substances. The ground substance is composed of glycosaminoglycans 
(long and unbranched polysaccharide units), proteoglycans (possess high degree of 
viscosity and has binding sites for signaling molecules) and glycoproteins (helps cells to 
adhere to extracellular matrix). These components help provide the support to the cells. 
For example, membrane-proteoglycans help bind cells to fibronectin (helps in blood 
clotting) and collagen fibers (structural support to cells) and glycoproteins that helps in 
regulating cells to adhere to the extracellular matrix. 
 Second, maintain Cellular Acitivity: The extracellular matrix is composed of two 
types of fibers, structural and adhesive fibers. For example, laminin, an adhesive fiber 
helps in cell adhesion and is involved in cellular migration and differentiation. Heparan 
sulphate, a glycosaminoglycan that is found on the surface of fibroblasts and epithelial 
cells helps mediate cell adhesion and angiogenesis (development of new blood vessels).  
 Third, regulate mechano-chemical properties: For example, keratan sulphate, a 
glycosaminoglycan, helps provide mechanical strength to the tissues and acts as a shock-
absorbed in joints and chondronectin, an adhesive glycoprotein present in cartilage 
tissues imparts structural strength. 
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 Fourth, involved in tissue remodeling and regeneration: For example, tenascin, an 
adhesive glycoprotein that is only expressed in embryonic tissues helps in cellular and 
tissue development. Another example of an adhesive glycoprotein is thrombospondin 
present in blood plasma and platelets is secreted during tissue injury to induce blood 
clotting while fibronectin, an adhesive fiber helps in the process of wound healing. 
 The right choice of material is a motivating factor for improving the living 
standards and be able to meet the high demands of the healthcare industry [56]. Given the 
ultrafine structure of ECM and the complexity [17], the structural/functional relationship 
it has with the cell growth and function, the questions that needs to be addressed for 
developing new biomimetic scaffold materials are: 
1. What aspects of the extracellular matrix are critical for mimicking a specific tissue 
engineering application? For example, mechanics of native extracellular matrix 
ranges from 0.1kPa in terms of elasticity for brain tissues to 80kPa for pre-calcified 
bone tissues or to achieve water-swollen networks like found in native extracellular 
matrix, hydrogels have been investigated which enables efficient diffusion of 
nutrients and soluble signals [57].  
2. How to achieve fidelity towards native ECM? For example, small pores present in 
biomaterials like hydrogels can impede cell infiltration while biomaterials that can be 
produced with fiber diameter between 50-500nm can mimic the length-scale of 
natural extracellular matrix [57]
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3. What is the best possible approach needed while designing a biomaterial that not only 
supports the cell growth in vitro but also is subject to extensive remodeling in vivo? 
For example, fibers in connective tissues support surrounding tissues and are involved 
in transport of nutrients or waste [58]. To mimic the architecture and function of 
connective tissues, it may be necessary for the biomaterial to be flexible with 
characteristic strength like collagen fibers in ligaments or tendons or have properties 
like stretching and compressing to mimic elastic fibers in skin or fabricate 
biomaterials with random fiber orientation to impart strength like dense irregular 
connective tissue in bone and the dermis of the skin [58].  
 While bio-based materials integrate well with host-tissue, improve healing 
process and are non-toxic [7] they lack the necessary mechanical strength. While 
synthetic materials can be manufactured with the ability to control shape, structure and 
reproducibility [17] they lack structural and functional molecules that resemble the native 
ECM. 
 Thus, it is not necessary that a given biomaterials should provide positive 
outcomes for multiple applications, but it is very important to understand the human 
biology, host response to the biomaterial and how great a fit it is for clinical applications! 
1.5. Tissue Engineering: Basic Principle 
 Tissue damage or end stage organ loss is generally treated by transplantation 
which is very challenging. According to organdonor.gov, US department of health and 
human, 34,770 transplants were performed in the year 2017 with 114,000 still on the 
transplant list as of August 2017 [59]. With this increase in number since 1991, the need 
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for alternate strategies and technologies is very crucial. This introduces us to the field of 
tissue engineering. Tissue engineering is a highly multidisciplinary approach utilizes the 
field of life sciences and engineering to restore, maintain and improve the functions of 
native tissues. The basic principle of tissue engineering is demonstrated in FIGURE1.  
 Briefly, the cells from donor patients or donor cells from the same species are 
extracted and cultured in the laboratory in tissue culture flasks. Second, the cells are then 
seeded on the biomaterial/scaffold of interest. These cell-scaffold constructs are 
engineered to support three-dimensional tissue function that should be biocompatible, 
non-toxic and support cellular functions like cellular adhesion, proliferation, 
differentiation and new tissue formation. The aim is developing a cell-scaffold construct 
that can support three-dimensional tissue formation. Finally, once the cell-scaffold 




Figure 1. Basic Principle of Tissue Engineering
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1.6. Study Goals 
 The main aim of this study is to define the properties of polysaccharide-based 
biomaterials for the facilitation of bone regeneration.  In this study, we use 
Gluconacetobacter hansenii as a source of nanoscale crystalline cellulose to mimic the 
three-dimensional architect of the extracellular matrix. The nanoscale dimensions of 
bacterial cellulose and its unique properties forms an ideal biomaterial for applications in 
the field of tissue engineering. A comprehensive knowledge of material properties of 
bacterial cellulose and the interaction of stem cells on bacterial cellulose towards 
osteogenic differentiation has been explained.  
The aims and objectives of this study are to: 
1. Define conditions for the use of Bacterial Cellulose (BC) as a biomaterial for 
tissue engineering applications 
 Optimize the process parameters to obtain a homogenous pellicle of 
cellulose from Gluconacetobacter Hansenii bacteria with uniform 
diameter of fibers, and thickness and weight of the BC pellicle. 
 Characterize the material properties of the synthesized biomaterial 
cellulose. 
 Determine cellular responses to BC, specifically cell adhesion, 




2. Characterize the biomineralization property of BC to be used as a bone 
biomaterial 
 To investigate the extent of mineralization using hydroxyapatite as a 
model material on BC. 
 To study the material properties of the synthesized biomaterial. 
3. Characterize the osteogenic differentiation of hPMSCs on BC biomaterial 
 Validate stem cell differentiation of stem cells by developing bioanalytical 
methods to quantitatively analyze the expression of biochemical markers 
of bone formation on BC biomaterial. 
 Define the cellular response of hPMSCs towards osteogenic differentiation 
on BC biomaterial. 
4. Develop a three-dimensional bacterial cellulose foam using túngara frog 
(Engystomops pustulosus) foam protein 
 To transform expression plasmid Ranaspumin-2 (RSN-2; a surfactant 
protein) into BL21 (DE3) bacteria. 
 To perform recombinant protein purification and characterization to 
demonstrate the foaming nature of RSN-2. 
 To demonstrate BC foam formation using RSN-2 as a template to 
fabricate 3-dimensional structure of BC.
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1.7. Dissertation Overview 
 This dissertation is divided into five chapters. Chapter 1 provides a detailed 
understanding of the background and discusses the aims and objectives of this study. 
Chapter 2 provides a brief understanding of polysaccharides and its different types while 
highlighting its application in the field of tissue engineering. Chapter 3 provides with 
detailed information on producing bacterial cellulose and the properties of bacterial 
cellulose that enable cellular responses of human-derived placental mesenchymal stems 
cells. Chapter 4 explains the application of bacterial cellulose in the field of bone tissue 
engineering, thereby highlighting on its mineralization property. The differentiation of 
human placental stem cells on bacterial cellulose biomaterial along with various 
biological assays and quantitative studies are a part of this chapter. Chapter 5 
demonstrates a novel idea of making bacterial cellulose biomaterial into a 3-dimensional 
structure by controlling its growth on the air-liquid interface by using the properties of 
surfactants. Here, the use of ranaspumin-2, a surfactant protein which is found in túngara 
frog’s foam nest has been described to be used as a template for producing bacterial 
cellulose foam structure followed by summarizing the study in this dissertation along 








 Nature has provided great inspiration to prepare materials that displays complex 
hierarchy and organization which promise to a wide a range of applications and meet the 
desired goal [60]. In the context of tissue engineering scaffolds that effectively mimic the 
morphology and functions of the extracellular matrix (ECM) native to the cellular 
environment are being designed [49]. These biomimetic materials will be critically-
important in the regenerative process with the need to grow and regenerate complex 
organs and tissues.  The ECM is primarily composed of proteoglycans, 
glycosaminoglycans, glycoproteins and glycolipids [49]. The ECM is a complex 
heterogenous material that is as diverse as the types and number of cells in the human 
body; the ECM provides a dynamic and controlled environment that directs cell 
migration, adhesion, proliferation and differentiation, while being remodeled as needed 
[49]. 
 Polysaccharides have gained much interest in the recent years as they provide 
excellent functional and mechanical cues that resemble the innate state of the native 
tissues, and are biocompatible, non-toxic, renewable and available in abundance [49].  
21 
 
They have a range of mechanical properties that which have encourage a wide range of 
applications in the biomedical field. 
2.2. Definition of Polysaccharides 
 Polysaccharides are natural polymers that are composed of long chains of 
monosaccharide units which are covalently connected by glycosidic linkages as shown in 
FIGURE 2. The general formula of polysaccharides is (CnH2nOn). They are materials 
that are derived from natural sources like plants and bacteria and are present in most 
living organisms. They are further classified as linear or branched chain depending upon 
the type of monosaccharide unit [61]. Their chemical structure further possesses many 
reactive functional groups like hydroxyl and carboxylic acid groups that feature the 
possibility for chemical modifications and formation of new composite materials. The 
need for polysaccharides has an emerging interest as it is helping replace the use of 
conventional non-biodegradable and non-disposable petroleum-based materials that 
causes environmental problems like landfill disposals, air-borne particulates and 





Figure 2. Chemical Structure of (top) Monosaccharide (example: glucose);  
(bottom) Polysaccharide (example: amylose starch) 
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2.3. Types of Polysaccharides 
 Polysaccharide ordered structures are categorized into structural and storage 
polysaccharides as shown in FIGURE 3. Cellulose and chitin are examples of structural 
polysaccharides. They are formed of many glucose monomers that combine to form long 
fibers. While these polysaccharides have linear and long fibers that are deposited outside 
the cell membrane, storage polysaccharides like glycogen and starch are formed due to a 
spiral pattern [64, 65]. They form clusters with the help of a combination of proteins that 


















2.4. Polysaccharides as Cellular Support 
 Tissue engineering and regenerative medicine needs attention in developing 
biomaterials for regeneration of damaged tissues as human body is a sensitive and 
complex biological framework. The need for biomaterials has risen in tissue engineering 
for cost-effective surgical procedures [66]. Some of the important properties that a 
biomaterial must deliver are biocompatibility, biodegradability and structural integrity. 
Polysaccharide polymers have been used to support these properties along with high 
porosity, increased surface area, low cost and moreover, polysaccharides support the 
cellular functions like adhesion, proliferation, migration and differentiation [62]. 
Polysaccharide polymers like chitosan, hyaluronic acid, alginates and cellulose are 
extremely versatile materials which can be formed into hydrogels to provide mechanical 
support for applications like drug delivery, stem cell differentiation and as a template for 
controlled tissue growth [67]. The different kind of polysaccharides used in the 
biomedical field are starch, fibrin, silk, hyaluronic acid, collagen, etc. that help mimic 




Figure 4. Fabrication of Polysaccharides into Different Structure Types and Its 




2.4.1. Chitin and Chitosan 
 Chitin and it’s alkaline deacetylated derivative chitosan are structural 
polysaccharides that comprise the exoskeletons of arthropods and cell walls of fungi [49, 
62, 68, 69]. The annual production of chitin by living organism is estimated to be over a 
trillion tons/year [62, 70]. Chitin is a natural amino polysaccharide that consists of 
randomly arranged D-glucosamine and N-acetyl-D-glucosamine residues [49] as shown 
in FIGURE 5. The degree of deacetylation of chitosan varies between 75% and 95%. If 
the content of N-acetyl-D-glucosamine is higher, the polymer is chitin and if the content 
of glucosamine is higher, the polymer is chitosan [71]. Chitosan has unique properties 
like antimicrobial, anti-inflammatory, anti-fungal, antioxidant and mucoadhesiveness in 









2.4.1.1. Tissue Engineering Applications 
 Many material properties of chitin that make it an attractive biomaterial for cell 
scaffolds are due to its chemical resemblance to naturally occurring substances in human 
body like glycosaminoglycans and amine groups in the polypeptides [72]. These 
properties are exhibited due to chemical resemblance to naturally occurring substances in 
human body like glycosaminoglycans and amine groups in the polymeric chain [72]. The 
chemical structure of chitin/chitosan also enhances its utility as a scaffold material. The 
free amine groups provide a simple means of functionalized this polysaccharide for many 
applications. For instance, nanoparticle functionalization of chitosan by the addition of 
nanoparticles have enhanced its materials properties, such as its mechanical durability 
and antimicrobial activity for its applications in burn wound regeneration [72]. Here, 
Chitosan scaffolds that had been doped with silver nanoparticles exhibit increased 
fibroblast cell adhesion and proliferation; interestingly, the rate of proliferation was a 
function of deacetylation which controls porosity and available surface. Chitosan and 
chitin have also been demonstrated to have inherent synthetic properties for the 
generation of silver nanoparticles and silver nanowires through the interactions of metal 
ions with these nitrogenous functional group, which seem to function in the nucleation 
and stabilization of the nascent materials [73]. However, chitosan and chitin have some 
challenges including low or no solubility in aqueous solutions and difficulty in 
controlling nanoscale and microscale organization, which is critical for controlling many 
of its mechanical properties [68, 69, 74, 75]. One way in which these issues have been 
overcome is through the applications of chitin/chitosan in polymer composites through 
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electrospinning processes [76-78]. Electrospinning is a process of creating long fibers 
when an electric field is applied between the collector and the polymer source. This 
electric potential forces the polymer solution to erupt, moving towards the collector and 
solidifying into fiber [79]. Polyglycerol sebacate/chitosan/gelatin nano-composite 
scaffolds have been used for nerve tissue engineering applications [77]. Once again, a 
mixture of other polymers, in this case, semi-crystalline polyglycerol sebacate and gelatin 
were used to enhance the electrospinning of chitosan under different electrospinning 
conditions. Chitosan as a component to composite hydrogels can also add desirable 
properties [78]. Chitosan was added to another nerve cell scaffold to enhance the 
hydrophilicity of poly(ε-caprolactone) and the electrically conductive polymer 
polypyrrole as well as increasing the adhesion and proliferation of the PC12 nerve cells 
[78]. 
2.4.1.2. Chitin and Chitosan for Bone Tissue Engineering 
 Chitin/chitosan have been considered as excellent materials for bone tissue 
engineering because of their mechanical properties as well as their functionalization that 
enables interactions with soluble metal ions [80].  In this context several groups have 
used these biopolymers as scaffolds usually as a component to composite material due to 
their structure like glycosaminoglycans; an important component of the extracellular 
matrix of bone [81]. 
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 For instance, a tricomponent bioactive nanocomposite made of nano-
hydroxyapatite, chitosan and Trigonella foenum graecum Seed polysaccharide (TFSP) 
using co-precipitation method demonstrated improved mineralization [82]. This study 
used adenosine diphosphate (ADP) as a crosslinking agent for the fabrication of chitosan 
sponges. MC3T3 pre-osteoblasts differentiation on apatite-chitosan sponges showed 
improved biomineralization as compared to chitosan alone. Similarly, an injectable 
apatite-chitosan sponge construct showed improved biomineralization by MC3T3 pre-
osteoblasts differentiation on apatite-chitosan sponges as compared to chitosan alone 
[81].  
 Chitosan has been used in bone tissue engineering due to its intrinsic antibacterial 
nature, ability to be molded into different shapes likes fibers, sponges, beads and films 
and formation of porous structures that support cell growth [83]. As chitosan lacks 
mechanical properties and itself is not osteoconductive, its application in the field of bone 
tissue engineering has improved by addition of ceramic materials that forms chitosan 
composite while mimicking the organic portion of the natural bone[83].
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2.4.2. Hyaluronic Acid 
 Hyaluronic acid is a glycosaminoglycan polyssacharide that is comprised of 
repeating disaccharide units of N-acetyl-d-glucosamine and d-glucuronic acid as shown 
in FIGURE 6 and is synthesized by hyaluronan synthases and degraded by a family of 
enzymes called hyaluronidases [84]. Hyaluronic acid is a main component of the 
mammalian that is critical for the regulation of cell growth, cell migration and cell 
differentiation. It is also a major component of loose connective tissue, skin and the eye 
[85]. Hyaluronic acid has mechanical properties that enable it to function as a joint 
lubricant [86], shock absorber (in synovial fluid[85]), space filler, tissue damper, shear 




Figure 6. Chemical Structure of Hyaluronic Acid 
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2.4.2.1. Tissue Engineering Applications 
 Hyaluronic acid has been used in a few applications such as for soft tissues, bone 
regeneration, periodontal tissue, as an anti-cancer drug delivery as well as a protein 
delivery vehicle [88]. Hyaluronic acid has been used to stimulate angiogenesis; formation 
of a vascular network [89]. H. Kenar et al. fabricated collagen/hyaluronic acid-based 
poly(L-lactide-co-ε-caprolactone) (PLC/COL/HA) microfibrous scaffold using 
electrospinning. Adipose tissue-derived mesenchymal stem cell cultured on the scaffold 
showed improved adhesion and proliferation. Further, human umbilical vein endothelial 
cells were co-cultured for neovascularization. The study confirmed the formation of 
capillaries on PLC/COL/HA as compared to only PLC. E. Jooybar et al. studied HA for 
cartilage tissue engineering [90]. Injectable hyaluronic acid-tyramine (HATA) hydrogel 
was incorporated with plate-lysate (PL). PL is an inexpensive source of growth factors 
obtained from the peripheral blood of patients. The study concluded that the 
incorporation of PL did no significant effect on cell chondrogenesis, the scaffold HA-TA-
PL did support the differentiation of human mesenchymal stem cells and can support as a 
cartilaginous construct. HA is also known as a skin’s best friend. It provides hydration 
and promotes a healthy glow for the skin. To further study its effect on skin, A. Chanda et 
al. fabricated chitosan (CS)/ polycaprolactone (PCL) and hyaluronic acid (HA) using 
electrospinning [91]. Reduced bacterial adhesion was observed which demonstrates 
antimicrobial activity of the scaffolds along with proliferation, adhesion and viability of 
kidney epithelial cell in vitro. 
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 The applications of HA has been limited due to its short residence time as well as 
lack of mechanical integrity, yet it exhibits many advantageous properties like 
biocompatibility, as a lubricant for joint tissues and it can maintain its hydrated state that 
allowed for cell infiltration [88]. 
2.4.2.2. Hyaluronic Acid for Bone Tissue Engineering 
 In the field of bone tissue engineering, hyaluronic acid has been used extensively 
as a composite material with other synthetic and natural polymers [49]. The use of 
hyaluronic acid in this capacity is natural as this polysaccharide has important role in the 
formation and development of bone during embryogenesis [92, 93]. A biomimetic 
scaffold that was composed of chitosan, chondroitin sulfate (CSA) and hyaluronic acid 
and which included nano hydroxyapatite demonstrated in vitro mineralization in 
simulated body fluid and supported the proliferation, adhesion and mineralization of 
osteoblasts [94]. Another composite of chitosan, Hyaluronic acid and graphene oxide 
enhanced the mechanical properties and functionality of the composite showed increased 
activity of mineralization and differentiation of MC3T3 cells as compared to scaffolds 
when stimulated by the osteogenic drug simvastatin [95].   
The applications of hyaluronic acid in the field of bone tissue engineering has 
been used as a bone morphogenetic protein delivery vehicle for bone regrowth [88], 
supporting material for bone grafts to enhance physical and chemical properties of grafts 
materials to accelerate bone regeneration [96] and as a composite with beta-tricalcium 
phosphate for improved osteoconductive properties [96]. Since the mechanical properties 
of hyaluronic acid is weaker than the natural bone, it requires the use of other materials to 
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support the cell-scaffold construct for bone tissue engineering as described by some 
examples listed above [97]. 
2.4.3. Cellulose 
 Cellulose is a polysaccharide that consists of the linear arrangement of β-(1→4)-
linked-D-glucose units as shown in FIGURE 7. Cellulose is the most abundant organic 
polymer found on the Earth as it is a structural component of plant cell walls and the 
primary structure component of wood, paper and cotton [49, 62].  Pure and crystalline 
nanoscale version of cellulose are also produced by a range of microorganisms including 
the Gram-negative and Gram-positive bacteria like Acetobacter, Sarcina ventriculi, and 
Agrobecterium and specific algae species such as Gelidium elegans and Gelidium 
amansii  [62, 98].  
 The molecular formula of cellulose is (C6H10O5)n in which n varies depending 
on the type of cellulose like native cellulose, oxycellulose, microcrystalline cellulose, etc. 
[99]. Cellulose has a flat ribbon-like conformation and engages in intramolecular 
hydrogen bonding with other cellulose polymers. The intramolecular interaction enables 
cellulose to crystallize, form fibrillary strands, possess high viscosity and alters its 
stiffness[62] . Cellulose is biocompatible polymer that chemically resembles the 
glycosaminoglycans (GAGs) in the extracellular matrix (ECM) of the human body [48]. 
Due to its low inflammatory response in its in vivo application, sustainability and easy 




 Due to its crystalline and ordered structure, cellulose is insoluble in water and 
many solvents, which limits some of its applications. However, crystalline nanocellulose 
has extraordinary properties include high water-holding capacity, can be produced in 
different shapes and sizes, ability to form different compounds due to the presence of 
hydroxyl groups, highly crystalline, high tensile strength and has wide range of  




Figure 7. Chemical Structure of Cellulose 
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2.4.3.1. Tissue Engineering Applications 
 Different chemical modifications such as oxidation, esterification and 
micronization of cellulose are performed to produce cellulose derivatives for specific 
applications ranging from packaging to pharmaceuticals. A water-soluble derivative of 
cellulose ether was used as a scaffold for skin tissue engineering along with poly (vinyl) 
alcohol (PVA) for improved mechanical, chemical and physical properties [48]. Here, 
F.H. Zulkifli et al. showed human fibroblast growth on this composite scaffold along with 
improved degradation on hydroxyethyl cellulose/PVA with higher degradation observed 
on the composite scaffold with lowest percentage of PVA in the blend. J. Joy et al. 
fabricated gelatin-carboxymethyl cellulose using electrospinning for vascular tissue 
engineering [51]. Oxidized carboxymethyl cellulose was used to overcome the problems 
associated with other crosslinking agents like cell growth inhibition (glutaraldehyde) and 
increased cost of production (genipin). The scaffolds were non-toxic towards BALB/c 
3T3 cells in vitro with complete resorption of the material in rats with no inflammation 
during the healing process. As porous cellulose is difficult to produce without 
electrospinning, J.W. Lee et al. produced porous film using cellulose and Poly (m-
phenylene isophthalamide) (PMIA) using coagulation process with a peel-off method as a 
skin contruct [52]. Further, the scaffold supported the growth of human keratinocytes and 
showed no cytoxicity in vitro. Another study used cellulose acetate electrospun fibers for 
skin tissue engineering [101]. This study engineered the scaffold with the use of pullulan 
(produced by omnivorous fungi species Aureobasidium pullulans) to improve the height 
of the 3D construct, porosity and biostability. Further, pullulan acts as a stabilizer, an 
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adhesive and as a binder in various applications like wound healing and dentures. Mouse 
fibroblastic cell line (L929) showed cytocompatibility as they adhered and proliferated on 
the scaffold. Cellulose has also been studied for its application in cartilage tissue 
engineering. In order to demonstrate strong mechanical characteristics of three-
dimensional scaffolds for application as a connective tissue, nano-reinforcement clay 
known as laponites were used to enable a strong gel structure [102]. Here, C. Boyer et al. 
fabricated injectable laponite nanoparticle-associated silated hydroxypropylmethyl 
cellulose and showed no side-effects with respect to cytocompatibility of human adipose 
stromal cells (hASC) cells due to laponite. The study also showed the formation of 
cartilaginous tissue post implantation in subcutaneous pockets of nude mice. Further, to 
combat neural disorders like Alzheimer’s disease (AD), Parkinson’s disease, and spinal 
cord injuries human and animal studies have limitations while conducting brain research. 
V. Kuzmenko et al. used cellulose nanofibril and carbon nanotubes as a conductive and 
composite ink to 3D print a neural construct [103]. This scaffold supported the growth 
and proliferation of the SH-SHY5Y human neuroblastoma cells in vitro and found cell 
communication via neurites.  
 A crystalline /nanoscale form of cellulose is synthesized by a variety of microbial 
species of bacteria like those of the genus Acetobacter, Achromobacter, Alcaligenes, 
Aerobacter, Agrobacterium. The chemically pure structure of these bacterial cellulose, 
along with the fibrous nanoscale morphology provides these cellulose materials with 




 Furthermore, given the source of these cellulose along with simple production 
method, bacterial nanoscale cellulose has wide range of potential applications to the field 
of tissue engineering [47, 104].  Currently, bacterial nanoscale cellulose is used in a 
variety of applications including treatments of severe burns and cell scaffolds[47] . 
A bacterial cellulose nanocomposite with the keratin protein for skin tissue engineering 
demonstrated enhanced binding of dermal fibroblasts and keratinocytes in vitro [50]. In 
this composite, keratin proteins specific cell adhesion binding motifs while the bacterial 
cellulose provided a mechanically stable platform. In the field of skin tissue engineering, 
bacterial cellulose/monmrillonite nanocomposite modified with Cu, Na and Ca not only 
improved tissue regeneration and wound healing in burnt mice but also also showed 
antimicrobial properties against pathogens associated with skin burns [105]. A porous 
bacterial cellulose/gelatin heparin hydrogel loaded vascular endothelial growth factor 
(VEGF)-loaded 3D (B/G) improved proliferation and migration of endothelial cells 
(PIECs) in vitro with angiogenesis observed by the application of the scaffold in an in 
vivo study [106].  
 BC is an extracellular polymer produced by many microorganisms using semi-
synthetic or agricultural wastes media solution [107]. Though microorganisms like 
Salmonella spp. and Escherichia coli (E. coli) have the potential to produce cellulose, the 
amount of cellulose produced by G.xylinus is still higher [108]. The nanoporous structure 
along with free hydroxyl groups allows for many applications in the field of tissue 
engineering along with fabrication of nanocomposites [107].  
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 The high surface area represents bacterial cellulose as an exciting class of 
nanomaterial to be used as a biopolymer for applications such as an artificial blood 
vessel, wound dressing, bone regeneration as well as for dental implants [109]. Further, 
the polysaccharide nature of bacterial cellulose makes it non-immunogenic; adding to its 
biocompatibility [109]. Some of the current limitations of bacterial cellulose despite its 
unique structure and excellent properties include high production cost on a large scale, 
low availability of an industrial fabrication line and inconsistency in quality [109].  With 
bacterial cellulose still being used as a dessert called ‘nata de coco’ to an ideal candidate 
as a scaffold in tissue engineering, this non-allergenic nanopolymer to be designed and 
used in the biomedical field [108]. 
2.4.3.2. Cellulose for Bone Tissue Engineering 
 Derivative of cellulose have been widely used to construct biodegradable 
scaffolds for bone tissue engineering [99, 110]. The use of natural polysaccharides came 
into effect when synthetic materials like polyesters did not offer uniform degradation 
rates, acidic by-products upon degradation and needed toxic solvents to dissolve these 
materials. To overcome these problems, researchers utilized the idea of blending natural 
and synthetic materials to offer good biocompatibility, biodegradability and better 
mechanical strength to be used as a scaffold for bone growth. Hydroxyethyl cellulose and 
polyvinyl alcohol composite with higher ratio of cellulose to polyvinyl alcohol supported 
human osteosarcoma cells in vitro and resulted greater proliferation of these cells that 
composts with lower ration, which suggests that the cells preferred higher content of 
cellulose which reflects that the cellulose closely mimics the native extracellular matrix 
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due to presence of β-glucose linkage and also shown to play an important role in the 
metabolism of the body. [111]. Another study fabricated a nanocomposite scaffold of 
cellulose-graft-polyacrylamide/nano-hydroxyapatite and showed mineralization on the 
scaffold when subjected to simulated body fluid study suggesting the formation of apatite 
layer [112].  
 To utilize the high purity of cellulose from bacteria as a property along with high 
hydrophilicity and mechanical strength, P.M. Favi et al. showed the osteogenic and 
chondrogenic ability of bacterial cellulose (BC). Equine-derived bone marrow 
mesenchymal stem cells were cultured on the scaffold and tested positive for alizarin red 
staining (Osteogenic differentiation) and alcian blue staining (Chondrogenic 
differentiation) in vitro [113]. Q. Shi et al. studied osteogenesis of bacterial cellulose 
scaffold with an aim to demonstrate the ability of BC to be used as a localized delivery 
system. This study showed that BC loaded with bone morphogenetic protein-2 caused 
better differentiation of mouse fibroblast-like C2C12 cells in vitro and better 
development of bone as well as calcium formation in Male Spraguee Dawley (SD) rats as 
compared to native BC [114].  
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 Cellulose has a growing interest in the field of material science due to its 
availability in abundance, high purity, sustainability and biodegradability [115]. Bacterial 
cellulose has gained considerable interest due to its high purity as compared to plant 
cellulose and other modified forms of cellulose. The bacteria produce high amounts of 
cellulose with nano crystalline structure and possessing high water holding capacity. 
These properties make bacterial cellulose a potential candidate for tissue engineering 
applications. In this study, bacterial cellulose has been used with a detailed understanding 
of the material in its never-dried state following a key question: ‘Can native never-dried 
bacterial cellulose be an ideal candidate for the osteogenic differentiation of human-








 Cellulose produced by bacteria was first discovered by A.J. Brown in 1886 from 
Acetobacter xylinum [108]. The gelatinous and slippery bacterial cellulose is composed 
of pure form of cellulose with no lignin [116]. Bacterial cellulose (BC) has been long 
used by the Philippines as a raw material for its dessert food called nata-de-coco which is 
prepared by fermenting with coconut water and is immersed in a sugar syrup [116]. This 
product is now manufactured in Indonesia and even exported as a healthy diet [116]. The 
molecular formula of bacterial cellulose is (C6H10O5)n , having a β-1,4 linkage between 
two glucose molecules [117].  It is composed of nano and micro-sized fibrils arranged in 
random direction. Typical chain elongation rate is 2 μm/min. Inter- and intra-hydrogen 
bonding hold the glucan chains together in the bacterial cellulose structure as shown in 






















 Cellulose producing bacteria synthesize nanoscale ribbon-like structure, of the 
dimension 40nmX60nm (width/height) with different crystallinity; either a cellulose-I 
structure or a thermally stable structure which is that of a cellulose-II structure [118]. 
This is because there are 50-80 pore-like sites on the surface of the cell which are 
presumed to be the sites of extrusion of precellulosic polymers which results in the 
association of glucan chains, aggregates, microfibrils, bundles and ribbons [119]. But 
when there is strong aeration and or there is presence of certain substances that can form 
hydrogen bonds with the β-1-4 glucan chains then cellulose II structure is formed instead 
of cellulose I [119].  These two allomorphs of cellulose have distinguishable properties. 
Cellulose-I has parallel glucan chains which consists of strong H-bonding patterns. This 
gives the structure high crystallinity but is less stable. Cellulose-II has low crystallinity as 
their H-bonding pattern is less ordered [120]. 
3.2. Bacterial Cellulose Synthesis 
 The bacterial cellulose synthesase complex is encoded by four genes  (BCsA, 
BCsB, BCsC, BCsD), which are encoded by the bcs operon [120] [121]as shown in 
FIGURE 9. This enzyme was first characterized in the acetic acid bacteria, 
Komagataeibacter xylinus (K. xylinus) [120].  The bacterial cellulose biosynthesis 
pathway as proposed in Acetobacter xylinum contains seven distinct steps in which a 
monomer of glucose is assembled into a cellulose polymer which is then exported 




To better understand the process of bacterial cellulose production it is important 
to study the biochemical synthesis pathway [122]. First, Glucokinase, phosphor- 
glucomutase and uridine triphosphate (UTP)-glucose1-phosphate uridylyltransferase 
transforms glucose to glucose-6-phosphate, glucose-1-phosphate, uridine diphosphate 
(UDP)-glucose. Further, in the presence of cellulase synthase UDP glucose transforms to 
bacterial cellulose which is unbranched β-1,4-D-glucan. Other sources of carbon which 
can be transformed to glucose are also used to improve the yield of bacterial cellulose. 
The bacterial cellulose synthase enzyme is a transmembrane complex that resides on the 
apical surface of the bacteria in a linear arrangement of 50-80 synthase complexes. 
BCsA encodes an integral inner membrane protein with a a small N-terminal domain and 
a large intracellular catalytic glycosyltransfersase domain. The C-terminal catalytic 
domain which contains a cyclic di-GMP/diguanylate PliZ domain, which is an activator 
of cellulose synthase enzymes, that control the synthesis of cellulose production. 
BCsB encodes a periplasmic polypeptide that binds to BCsA through a single C-teriminal 
helix. The BCsB protein contains two carbohydrate binding domains, CBD1 and CBD2, 
which stabilizes the transfer of the monosaccharide additions to the growing cellulose 
polymer chain. The growing cellulose polymer is fed and transported to the cell 
exterior/periplasmic space through a pore complex composted of proteins encoded by 
BCsC and the periplasmic polypetide encoded by BCsD. 
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 Both protein products encoded by BCsC and BCsD are both involved in the 
maximization of BC production and crystallization by limiting the export of glucan 
chains and crystallization of the bacterial cellulose nanoribbon through the peptidoglycan 
layer found in the cell wall of gram-negative bacteria [122]. FIGURE 10 explains the 
biochemical pathway as proposed in Acetobacter xylinum. Further, the site of cellulose 









Figure 10. Bacterial Cellulose Biochemical Pathway
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3.3. Parameters to Produce Bacterial Cellulose 
 Bacterial Cellulose has high crystallinity, purity and strength. It is necessary to 
optimize its production as it is a very important material in many industrial applications 
such as batteries, electronics and is gaining attention in the medical field too.  
The factors that affect the production of cellulose include culture/growth medium, 
environmental conditions and the presence of any by-products formed during the process 
[119]. The different methods to improve the production of bacterial cellulose are 
described below [119, 124]: 
 Culture Media: The three different types of media used to optimize yield of BC 
are Hestrinn-Schramm (H), Yamanaka (Y) and Zhou (Z) with each having 
optimum concentration of carbon and nitrogen sources [125]. Each of these media 
have different sources of carbon while maintaining a uniform pH of 5.5. Alternate 
methods to produce bacterial cellulose is by using feed stock like food processing 
effluents, molasses, fruit juice, rice bard and wheat straw as they are present in 
abundance, are low cost as well as impose no hazardous impact to the 
environment [104].  
 Carbon and Nitrogen Sources: Date syrup, sucrose, mannitol, fructose, lactose, 
maltitol, sucralose, xylitol, glycerol and galactose are some of the alternate carbon 
sources to glucose. The need for alternate sources was important as using glucose 
causes the formation of gluconic acid which decreases the pH of the medium and 
leading to decrease in cellulose production [119]. Yeast extract, corn steep liquor 
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and peptone are some of the nitrogen sources used as nitrogen is necessary for cell 
metabolism[119].  
 Other nutrients: phosphorus, sulfur, potassium and magnesium salts. Along with 
the carbon and nitrogen sources, the presence of ethanol, amino acids and 
vitamins also enhance the produce of cellulose [119]. The other factors that can 
help optimize bacterial cellulose production are pH and temperature [126]. The 
optimal temperature is around 28֯C and 30֯C and the pH is in the range of 4.0 to 
6.0.  
 The most optimum methods for producing bacterial cellulose are static culture 
and agitated culture as they are affordable bench techniques.  
 Static culture: When bacteria is immersed in the culture medium under static 
conditions, a cellulose biofilm of varying thickness is formed at the air-liquid 
interface [119]. The colonized bacteria at the air-liquid interface helps maintain 
the level of oxygen, protects the culture from drying while producing gelatinous 
pellicle with the doubling time of bacteria to be around 8-10 hours [119, 127]. 
 Agitated culture: Under agitated conditions, the oxygen is supplied by forced 
aeration as this improves bacterial respiration while producing cellulose with 
more fibrous morphology [119, 127]. The doubling time of bacteria is around 4-6 
hours [119]. As compared to static culture, agitated culture produces cellulose 
with lower Young’s modulus and crystallinity due to shear stress produced during 
agitation [127]. Further, the bacterial cellulose build-up under shaken conditions 
causes reduction in culture homogeneity which affects reduction in oxygen levels 
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[127].  Necessary modifications are being experimented to overcome these 
limitations like using airlift reactors, rotating disk reactors as well as trickling bed 
reactors for industrial applications [119, 128].  
 Komagataeibacter xylinus appears to be an interesting species from all the 
different types of acetic acid bacteria due to its ability to produce fibrils in the nano-
micro scale [129]. Exploitation of bacterial cellulose gradually grew starting from the 
food industry to outperform currently used celluloses as food dressings, sauces and 
gravies and frozen dairy products [129]. But, because of the lack of fermentation tanks, 
the commercial development of bacterial cellulose was never achieved [129]. The added 
disadvantages of fermentation tanks also include high production and capital cost which 
has caused the process of producing cellulose at a larger scale relatively slower [129]. 
But, cellulose in the medical field came into effect when Johnson & Johnson tried to 
commercialize back in the 80s which lead to several industrial products by various 
companies like XCell for wound care, Biofill and Bioprocess for skin burns and ulcers 
and Gengiflex for periodontal diseases [129]. With bacterial cellulose entering intro drug 
delivery area the question that how bacterial cellulose will be produced on a larger scale 
stills needs to be answered. 
3.4. Types of Cellulose Producing Bacteria 
 Bacterial cellulose is a renewable biomaterial that is produced by many species of 
bacteria including Rhizobium leguminosarum, Burkholderia, Pseudomonas putida, 
Dickeya dadantii, Erwinia chrysanthemi, Agrobacterium tumefaciens, Escherichia coli, 
and Salmonella enterica, however only three genera (Gluconacetobacter, Acetobacter, 
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and Komagataeibacter) produce this material in enough quantities and under 
standardized conditions to make them commercially important [119, 120]. TABLE 4  
summarizes the different types of bacteria with varied cellulose morphology [122]. 
 
 
Table 4. Types of Cellulose Producing Bacteria 
Organism (genus) Type of Cellulose Produced 
Acetobacter Extracellular pellicle 
Achromobacter Cellulose ribbons 
Aerobacter Cellulose fibrils 
Agrobacterium Short fibrils 
Alcaligenes Cellulose fibrils 
Pseudomonas No distinct fibrils 
Rhizobium Short fibrils 
Sarcina Amorphous cellulose 
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3.5. Properties of Bacterial Cellulose 
 Unlike cellulose derived from plant sources, cellulose produced from bacteria is 
very pure lacking hemicellulose (a branch polysaccharide with 1-6 glucose linkages in 
addition to 1-3 linkages), lignin (a heterogeneous complex organic molecule which 
provides molecular structure to plant cellulose) and pectin (another branched 
polysaccharide). Furthermore, bacterial cellulose has higher degree of crystallinity and 
polymerization. It has a degree of polymerization between 2000-6000 [122, 130-132]. 
The most important property of bacterial cellulose for biological engineering is that it is 
highly biocompatible because the polysaccharide nature of bacterial cellulose makes it 
non-immunogenic and possess similarities with the extra cellular matrix structure in vivo 
[109] . Bacterial cellulose has many hydroxyl groups due to which the fibers demonstrate 
a property of self-assembly and production of cellulose sheets with high porosity and 
surface area [109]. BC has high water holding capacity, crystallinity, mechanical 
strength, purity and offers the advantage of forming other nanocomposites due to 
presence of -OH groups which offers sites for synthesis processes [133].
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3.6. Applications of Bacterial Cellulose 
 Bacterial Cellulose is used a matrix material as well as a reinforcement material to 
form a nanocomposite. The unique properties of BC such as a high hydroscopic nature 
which makes the material highly hydrophilic, high tensile strength, the ability to produce 
different shapes, high crystallinity, sustainably sourced and substrates and the possibility 
of forming complex and novel composites due to the presence of -OH groups which 
offers sites for synthesis has offered potential applications. The table below (TABLE 5)  
provides various applications of bacterial cellulose [134]. 
 
 
Table 5. Applications of Bacterial Cellulose 
Type Description Reference 

















Blood Vessels As a vascular 
graft 
[139] 






Type Description Reference 











3.7. Bacterial Cellulose Immune Response 
 Biomaterials are required to be non-toxic and non-immunogenic [144]. Bacterial 
cellulose has gained attention in the biomedical field due to its unique properties like 
water absorption capacity, crystallinity and strength for its flexibility, nano and micro-
scale structure and better biological affinity than plant cellulose [144]. However, there are 
concerns on the immunoreactivity of bacterial cellulose both in vitro and in vivo. This is 
because lipopolysaccharides (LPS) is an endotoxin that is present in the outer membrane 
of gram-negative bacteria which can induce the production of inflammatory cytokines 
[144].  
 Lipopolysaccharides are also termed as endotoxin that covers 90% of the cell 
surface that acts as a physical barrier from antibacterial agents [145]. The structure of 
lipopolysaccharide consists of a hydrophobic domain known as lipid A (endotoxin), a 
non-repeating core of oligosaccharide, and a distal polysaccharide (O-antigen) [146]. It is 
detected as a marker for the development of inflammatory response and bacterial 
pathogen invasion [145]. The lipid A component is responsible for the toxic effects from 
gram-negative bacteria [147]. 
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 This innovative biopolymer was studied for its immunoreactivity by seeding 
human umbilical vein endothelial cells in an in vitro study [144]. Bacterial cellulose did 
not increase inflammatory cytokine levels - Interleukin-4 and interferon(IFN)-γ as 
compared to lipopolysaccharide-treated cells used a control [144]. Further, 
lipopolysaccharides not only induce inflammatory response but also stimulates T cells (a 
lymphocyte participating in immune response) [144]. This study also confirmed that 
bacterial cellulose did not stimulate CD4+ and CD8+ T cells [144]. To evaluate the acute 
oral toxicity of bacterial cellulose, Kunming mice were fed with small portions of 
bacterial cellulose[148]. This study showed no abnormal symptoms or differences in the 
anatomy of the organs or even death [148]. Another study evaluated the genotoxicity of 
bacterial cellulose in presence of Chinese hamster ovaries in vitro and showed that 
bacterial cellulose did not cause any DNA damage and found that bacterial cellulose was 
not genotoxic [149]. Bacterial cellulose has also been commercially used for skin injury 
treatments like Biofill® for severe body burns [148]. Bacterial cellulose face masks and 
face scrubs are some of the applications in the dermal tissue engineering that have not 
shown to cause any skin irritation or inflammation [148]. Bacterial cellulose has also 
been biocompatible without invoking any foreign responses in vivo. The implantation of 
bacterial cellulose as an artificial blood vessel [150], as a subcutaneous implant [151] , 
for cartilage tissue engineering [152], as an artificial dura mater [153] and the application 
of Bionext® as a dressing to prevent scarring tissue formation are all examples wherein no 
immune reaction were observed, strongly suggesting that bacterial cellulose is not 
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carcinogenic and tumor generator and does not generate any inflammatory response or 
oxidative stress at the cellular level [148].  
3.8. Experimental Section 
3.8.1. Materials and Methods 
3.8.1.1. Bacterial Cellulose Production 
 Gluconacetobacter hansenii was cultured in culture plate (6-well and 24-well) in 
a static culture at 30֯ C for a period of 4 days. The optimal culture medium consisted of 
(grams/liter): glucose 20, yeast extract 5, peptone 5, Na2HPO4 2.7 and citric acid 1.25. 
The BC pellicle obtained post culture was washed and soaked in sterile water for a period 
of 24 hours, boiled in 0.1N sodium hydroxide for 60 minutes and soaked in sterile water 
for 24 to 48 hours to a neutral pH. The pellicle was then autoclaved and stored in sterile 






Figure 11. Schematic of Bacterial Cellulose Culture Using Gluconacetobacter hansenii 
 
 
3.8.1.2. Morphology Characterization 
 Fiber diameter and morphology of BC were characterized using a Carl Zeiss 
Auriga-BU FIB FESEM Microscope (FESEM) (Carl Zeiss, Jena, Germany). Samples 
were first mounted on 1 cm2 stubs using carbon tape sputter-coated with ~3nm gold-
palladium using argon plasma Denton Vacuum Inc. Desk II Sputter Coater to avoid 
sample charging. Images were taken at a working distance of 5 mm and a gun 
accelerating voltage of 3 kV. The alignment of nanofibers was characterized using the 
fast Fourier transform method (FFT) using the FFT and orientation plug in for image j. 
The surface area and pore size were measures using Brunauer-Emmett-Teller (BET) 
Surface Analysis. Lyophilized bacterial cellulose were degassed at 120 ֯C for 3 hours 
followed by N2 adsorption at 77.144 K in a Micromeritics 3Flex 4.04.
61 
 
3.8.1.3. Chemical and Structural Characterization 
 Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectra was 
used to understand the chemical integrity of BC and BC-HA samples using Varian 670 
IR (Paulo Alto, CA). All spectra were recorded in a wavenumber range of 4000–650 
cm−1 with a resolution of 4 cm-1, accumulating 64 scans. The spectra of all samples 
were corrected for background. 
The X-Ray diffraction pattern for BC was characterized using an X-ray 
diffractometer (Gemini A Since Crystal Diffractometer, from: Rigaku Oxford Diffraction 
having CrysAlisPro Software System, Version 3.8.43) with a 1.540598 angstrom 
K(alpha)1 copper X-ray source. The operating voltage and current used was 40kV and 
40mA, respectively. 
3.8.1.4. Thermal Characterization 
 Thermal behavior of BC was determined by Differential Scanning Calorimetry 
(DSC) and Thermo-gravimetric analysis (TGA). DSC tests were performed with a Q200 
instrument (TA Instruments, New castle, DE, USA) under nitrogen atmosphere (nitrogen 
flowrate was 50 mL/min). The sample was heated from -20°C to 200 °C at the heating 
rate of 5 °C/min. The weight loss and the thermal stability of BC were measured by 
thermo-gravimetric analysis (TGA). TGA was performed by using Q500 
thermogravimetric analyzer (TA instruments, New Castle, DE, USA) under nitrogen 
atmosphere. The sample (8-10 mg) was placed in the crucible and heated in the 
temperature range of 25–800 ◦C with a heating rate of 10 ◦C/mi.
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3.8.1.5. Mechanical Characterization 
 The mechanical properties of BC were analyzed using MTS 858 Mini Bionix II. 
The BC sample were cut in a rectangular shape of the dimension 1cm X 6cm. They were 
cut in rectangular shape to enable fractures in the middle of the sample between the 
clamps. The thickness and the width of the BC sample was measured using a digital 
caliper. The distance between the clamps was maintained at 2cm and the sample was 
stretched at 5mm/min, until failure of the sample. The young’s modulus was obtained 
using Testworks software. 
3.8.1.6. Human-Derived Placental Mesenchymal Stem Cell (hPMSCs) Culture on 
Bacterial Cellulose Scaffold 
 Human PMSCs at passage 4 were additionally passaged 2-3 times in growth 
medium consisting of Minimum essential medium alpha modification 1X (HyClone, GE 
Healthcare Life Sciences, South Logan, Utah) supplemented with 17% AminoMax-C100 
1X basal medium (gibco), 15% fetal bovine serum (FBS from SIGMA-ALDRICH), 2% 
AminoMax-C100 supplement (gibco), 1% glutamax-1 (100X: gibco) and 10ml of 
antibiotic/antimycotic solution (A/A from HyClone, GE Healthcare Life Sciences, South 
Logan, Utah). All cell culture reagents were used as received unless stated otherwise.  
For all assays never-dried BC pellicles were seeded into wells of a 24-well tissue 
culture plates. BC samples were washed with 70 % ethanol followed by de- ionized (DI) 
water three times, sterilized under ultraviolet light for 2-4 hours and incubated in growth 
medium for 24 hours prior to seeding cells at 50k cells/well unless stated otherwise. 
Tissue culture plate (TCP) was used as control unless stated otherwise. 
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3.8.1.6.1. Adhesion Assay 
 hPMSCs were cultured on never-dried BC and tissue culture plate at cell seeding 
density of 50k cells/well and 10k cells/well respectively in complete growth medium. 
The cells were cultured for day 1 (post 24 hours) and day 5 and were fixed according to 
following protocol using the following protocol: each well was washed with 1X PBS and 
fixed with 4% paraformaldehyde in PBS for 15 minutes under incubation at 37◦C. The 
samples were washed 3 times with 1X PBS for two minute each followed by 
permeabilization using 0.2% Triton X-100 diluted with PBS for 15 minutes under 
incubation at 37◦C. Samples were rinsed again with 1X PBS three times for two minute 
each. 2% BSA was used as a blocking solution for 60 minutes under incubation at 37◦C. 
Nuclei were stained with DAPI and F-actin was detected using phalloidin. Laser scanning 
confocal microscopy was performed using a Carl Zeiss Axio Observer Z1, Spinning Disc 
Confocal Microscope (Carl Zeiss, Jena, Germany) and images were acquired at different 
magnifications. Confocal images were processed using the software and all quantitative 
images within a given experiment were captured using the same laser intensity and gain 
settings so that fluorescent intensities could be compared across sample.
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3.8.1.6.2. Viability and Proliferation Assay 
 hPMSCs were cultured on native never-dried BC at cell seeding density of 50k 
cells/well in complete growth medium for live/dead cell assay. The cells were cultured 
for day 1 (post 24 hours), day 3 and day 5. The plate was incubated at 37֯ C and 5% CO2. 
Live/dead stain was prepared by adding 2 µmol/L acetomethoxy derivate of calcein 
(calcein-AM) and 2 µmol/L ethidium homodimer-1 per millilitre of media. The plate was 
then incubated for 20 min and images were obtained using Leica DMI4000B 487-4. 
hPMSCs were cultured on never-dried BC at cell seeding density of 50k 
cells/well. The cells were cultured for day 1 (post 24 hours), day 3 and day 5 in complete 
growth medium for alamar blue assay. The plate was incubated at 37֯ C and 5% CO2. To 
measure viability, 10% (v/v) alamar blue was added to each well and the cultures were 
incubated at 37֯ C and 5% CO2. Viability was measured when the medium turned from 
blue to pink, typically at 4 h. Alamar blue fluorescence was measured using using a 
microplate reader (SpectraMax M5, Molecular Devices, Sunnyvale, CA, USA) with 
excitation at 560 nm and emission at 590 nm. 
3.8.2. Results and Discussion 
3.8.2.1. Morphology of Bacterial Cellulose 
 SEM analysis showed that a dried bacterial cellulose hydrogel is composed of a 
three-dimensional network of nanofibers. These nanofibers have an average diameter 
between 40-60nm and a helical twist due to the rotation of the bacteria during fibre 
foramtion [154]. In its native, ‘never dried state’, a bacterial cellulose  hydrogel is a 
translucent and gelatinous film (FIGURE 12 A and B), with interwoven cellulose micro-
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fibrils that are organized in random direction [117]. The material is flexible and resistant 
to tearing. Homogeneous pellicle of never-dried BC were obtained by maintaining the 
culture for a period of four days and incubating at 30֯C in a 24-well plate. The thickness 
of the pellicle was ~0.2mm with an average weight of 0.4 grams. Upon drying, bacterial 
cellulose becomes brittle as seen in FIGURE 12 D. FIGURE 13 shows the degree of fiber 
alignment using the fast Fourier transform method  (FFT). A borad distribution of 
nanofibers was  displayed which shows that the cellulose fibers produced by bacteria are 
in very random direction.  The BET analysis of bacterial cellulose (TABLE 6) showed 
that the material had a pore size of  8.9nm with an average pore size of 11.51nm. The 
nanometer range of pore size also accounts for a high surface area of ~24 m2/g. Bacterial 
cellulose showed a random fiber alignment with nanoscale orientation and a high surface 
area . These parameters make bacterial cellulose an ideal candidate for its application in 















Figure 12. Morphology of Bacterial Cellulose: (A): Scanning Electron Microscope 
Image, (B): Never-Dried Bacterial Cellulose Post Cleaning, (C): Confocal Microscopy 









Figure 13. Alignment of Bacterial Cellulose Fibers Using Fast Fourier Transform (FFT)  
Method (left), Histogram Plot Against the Angle of Acquisition (right) 
 
 
Table 6. BET Characterization of Bacterial Cellulose  
BET Surface 
Area (m2/g) 
BET Pore Size 
(nm) 
BJH Pore Size 
(nm) 
Density (g/cm3) 







3.8.2.2. Chemical and Structural Characterization 
 The FTIR spectrum of neat bacterial cellulose (FIGURE 14) is summarized in 
TABLE 7 with individual peaks, respective chemical groups and bonds observed from 
the spectrum [155]. 
 The x-ray diffraction of bacterial cellulose shown in FIGURE 15 demonstrates the 
characteristics peaks [156] for crystal plane (101), (10-1), (021), (002) and (040) which 
indicates the presence of both Iα and Iβ crystal cellulose and a typical crystalline form of  
cellulose I [155, 157, 158]. 
 
 
Table 7. FTIR Characteristic Peaks of Bacterial Cellulose 
Frequency Assignment Reference 




2913.94 CH Stretching [157] 
2892.74 CH2 Symmetric 
Stretching 
[157] 
1643 Absorbed H2O [160] 
1427.08 CH2 Symmetric 
Bending 
[157] 
1160.95 Antisymmetric Bridge 
C-O-C Stretching 
[157] 








Figure 15. X-ray Diffraction of Bacterial Cellulose
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3.8.2.3. Thermal Characterization 
 Thermogravimetric analysis of native bacterial cellulose allows us to understand 
the behavior of the material with temperature. As observed from the graph (FIGURE 16), 
the weight of the sample decreases with increasing temperature. The residual mass is 
negligible suggesting that there are no impurities in the bacterial cellulose sample. The 
thermal degradation of bacterial cellulose shows sequential dehydration, 
depolymerization, , and finally decomposition of glycosyl units, which is ultimately 
followed by the formation of charred residues [161]. The first weight loss for BC was 
between 5-6% which is attributed to desorption of water from the polysaccharide 
structure [162]. There is only one sharp peak observed at 311.73֯C which is indicative of 
cellulose degradation in one step with an onset degradation temperature around 200֯C for 
membrane dehydration. This also explains that the alkali treatment performed during BC 
cleaning as described earlier proved to effectively remove any impurities from the 
material. The maximum degradation of cellulose between 250֯C and 320֯C is when the 
glycosidic bonds within the fibers begin to break followed by decrease in fiber weight, 
degree of polymerization and crystallinity [160]. Our results prove that bacterial cellulose 
samples are highly stable at higher temperatures. This is an important property for 
sterilization of bacterial cellulose without changing its biophysical property as not many 
polymers can be sterilized above 100֯C [107].  
 The Differential scanning calorimetry allows us to identify the changes in the 
thermodynamic variables during the physico-chemical transformations [163]. The 
Differential scanning calorimetry thermogram shows an endothermic event range from 
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30֯C to 160֯C which is indicative of the dehydration of surface water. The melting 
temperature is 111.91֯C and the enthalpy is 159.3J/g. Membrane dehydration observed in 
DSC compliments the data observed in TGA further suggesting that melting followed by 





Figure 16. Thermal Analysis of Bacterial Cellulose: (top): Thermogravimetric Analysis, 
(bottom): Differential Scanning Calorimetry 
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3.8.2.4. Mechanical Characterization 
 Mechanical properties of bacterial cellulose were performed to evaluate its 
durability for its application in the field of bone tissue engineering.  A typical stress-
strain response of the BC material (FIGURE 17) in its never-dried state shows that this 
material has a linear elastic behavior followed by plastic behavior with an average 
young’s modulus of 23.4 MPa. The average ultimate tensile stress and strain at break are 
listed in the TABLE 8. While bacterial cellulose has been reported with Young’s 
modulus as high as 15GPa [164] (18 GPa of parietal bones of adult human skull [165]) 
depending on the cellulose content, the area of bacterial cellulose pellicle and material 
treatment (hot-pressed bacterial cellulose showed Young’s modulus of ~6.86 GPa [166]), 
the material with ~23 MPa may be suitable for non-load bearing sites like plate bones of  
face and skull [165]. 
 
 
Table 8. Summary of Mechanical Properties of Bacterial Cellulose 












Figure 17. Mechanical Analysis of Bacterial Cellulose Showing: (A): Bacterial Cellulose 
During Application of Load, (B): Bacterial Cellulose After Application of Load, (right): 
Stress-Strain Curve of Never-Dried Bacterial Cellulose 
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3.8.2.5. Human-Derived Placental Mesenchymal Stem Cell Culture on Bacterial 
Cellulose Scaffold 
3.8.2.5.1. Adhesion Assay 
 Although bacterial cellulose has been shown to be compatible with a broad range 
of cell types, to determine whether hPMSCs are compatible with bacterial cellulose we 
examine their proliferation and growth of these cells when cultured on these substrates.  
To do this, we cultured hPMSCs in a standard stem cell growth media on native never-
dried BC and tissue culture plate (TCP as control). The ability of the cells to interact with 
the scaffolds were studied based on adhesion, proliferation and cytoskeleton development 
on Day 1 (after 24 hours), and Day 5 as seen in FIGURE 18 and 19. Both BC and TCP 
showed the development of distinctive actin filaments(green) surrounding the 
nucleus(blue). There is also an increase in number of cells per field of view which 
demonstrate that the hPMSCs are proliferating on the materials. At the start of the 
experiment, the morphology of the hPMSCs was a generally round-shaped; however, by 
day five on BC scaffolds the hPMSCs morphology was elongated as demonstrated by the 
increase in actin length. The small spots of actin (FIGURE 2 E and F) suggest that the 
cells might be migrating from one place to other leaving behind a part of the filament. 
Although there is a difference in the proliferation of hPMSCs on BC as compared to 
TCP, these experiments clearly demonstrate that bacterial cellulose supports the in-vitro 




Figure 18. hPMSCs Culture on Bacterial Cellulose: (C): Day 1 Showing A: Nucleus, B: 
Actin Cytoskeleton; (F): Day 5 Showing D: Nucleus, E: Actin Cytoskeleton. 
Magnification: 20x, Green: Actin Cytoskeleton, Blue: Nucleus, Seeding Density: 50k 




Figure 19. hPMSCs Culture on Tissue Culture Plate: (C): Day 1 Showing A: Nucleus, B: 
Actin Cytoskeleton; (F): Day 5 Showing D: Nucleus, E: Actin Cytoskeleton. 
Magnification: 20x, Green: Actin Cytoskeleton, Blue: Nucleus, Seeding Density: 10k 
cells/well in a 24-well plate 
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3.8.2.5.1.1. Mechanical Stress Analysis 
 We examined the mechanical environmental of hPMSC when in contact with the 
neat never-dried bacterial cellulose scaffold and a glass coverslip control. The formation 
of focal adhesions during cell-substrate adhesion is a mechanically induced event that 
controls cell morphology and gene expression. During the focal adhesion integrins bind 
specific extracellular targets, typically components of the extracellular matrix via 
interactions with the RGD moieties found in these molecules. Intracellularly, this 
interaction stimulates the local assembly of filamentous actin as well as the recruitment 
of actin binding proteins and proteins associated with the focal adhesion. Some of the 
proteins such as talin are found at these intracellular cites, while other proteins such as 
vinculin localize to these sites in a mechanical strain induced manner[167]. By 
determining the ratio of a vinculin to integrin signal using standard densitometric analysis 
of confocal images, we can measure the relative mechanical stress that a cell is 
experiencing in a bacterial cellulose scaffold when compared to a control.    
 Further, the structural signaling molecules that are crucial for cell adhesion and 
help define the cell-extracellular matrix expression are studied by vinculin and integrin 
respectively, on BC and TCP scaffolds as seen in FIGURE 20 on Day 5. hPMSCs on BC 
as seen in FIGURE 20 A has a distinctive expression of vinculin as compared to TCP. 
The arrows indicate the focal adhesion points marked in red. There was no significant 
difference in the expression of vinculin observed on BC and control although bacterial 
cellulose showed a higher number of focal adhesion site. The expression of integrin 
affects cell survival, cell differentiation as well as cell motility which is of key interest in 
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this study shows that there was no significant difference in the ratio of vinculin/integrin 
between bacterial cellulose and control. This concludes that BC promotes the survival of 
hPMSCs while being able to support cell-scaffold expression that can be applied towards 
studying osteogenic differentiation of HPMSCs. TABLE 9 summarizes the  
vinculin/integrin ratio on never-dried BC scaffold and control. 
 
 
Table 9.   Densitometric Analysis 
Substrate Number of cells 
counted 
Average 











8 24±15.43 0.53±0.32 
Day 5 TCP-
HPMSCs 




Figure 20. Analysis of Mechanical Stress During hPMSCs Culture on: (A-C): BC and (D-
F): Tissue Culture Plate; Showing (A&D): Vinculin Expression, (B&E): Integrin 




3.8.2.5.2. Viability and Proliferation Assay 
 The toxicity of native never-dried BC was evaluated by culturing hPMSCs in-
vitro using the Live/Dead cell assay kit. The cells were cultured for Day 1(after 24 
hours), 3 and 5 as seen in FIGURE 21. The green color represents live cells and the red 
color represents dead cells. This study showed that BC is not only supporting the growth 
of hPMSCs but also is a viable scaffold for tissue engineering applications as compared 
to TCP. The material is non-toxic, biocompatible and supports the survival of hPMSCs in 
vitro. 
 FIGURE 22 shows cell viability and proliferation using alamar blue assay of 
hPMSCs on BC and TCP on Day 1 (post 24 hours), Day 3 and Day 5. The O.D. value 
increases over a period of 5 days on BC scaffold and TCP. TCP have a high proliferation 
rate with statistically significant difference between day 1 and day 3 and no significant 
difference between BC and TCP on day 1, 3 and 5. BC was not cytotoxic for hPMSCs 
culture and the proliferation and survival of the cells continued as compared to TCP were 
the confluency was achieved by the end of day 5 as supported by similar observations by 




Figure 21. Live/Dead Image of hPMSCs on Bacterial Cellulose: (A): Day 1, (B): Day 3, 
(C): Day 5 and hPMSCs on Tissue Culture Plate: (D): Day1, (E): Day 3, (F): Day 5. 

















 Bacterial cellulose pellicle was produced using Gluconacetobacter Hansenii 
under static conditions using mannitol as a source of carbon. The alignment of nanofibers 
occurs in random direction with an average diameter of 40-60nm and a thickness of 0.2 
μm after four days of culture in an incubator at 30֯C. The material obtained is hydrophilic 
in its never-dried state and becomes brittle upon drying. Characteristic peaks of neat 
bacterial cellulose were obtained using Fourier-transform infra-red spectroscopy showing 
intra molecular hydrogen bonding and glycosidic bonds. The thermal analysis showed 
that the material is stable up to 311.73֯C with the maximum degradation occurring 
between 250-320֯C. This allows for autoclaving as a sterilization method as the material 
can withstand higher temperature without causing change in material properties. The 
material also demonstrates good mechanical stability with an average modulus of 23 MPa 
in its never-dried state.  
 Since, bacterial cellulose offers biocompatibility with chemical and 
morphological controllability [168], it was studied for culturing human-derived placental 
mesenchymal stem cells in vitro towards osteogenic differentiation. The high surface area 
due to the nanoscale property of bacterial cellulose demonstrates native extracellular 
matrix behavior [169] which allows cells to express actin cytoskeleton and structural 
signaling molecules like vinculin and integrin. Further, the cells presented a more stacked 
morphology as compared to the tissue culture plate which shows enough cell spreading 
by the end of day 5. This could be either due to three-dimensional nature of bacterial 
cellulose (as the dense structure does not allow for cell migration [169]) which causes 
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slow cell spreading rate or lack of excellent bioactive molecules (like, collagen) that 
needs to be introduced along with bacterial cellulose to improve the formation of cell 
multilayer at an early stage of an in-vitro culture [168, 170]. Also, the pore size of 
bacterial cellulose as obtained by BET was 8.9094 nm. Since, the pore size of bacterial 
cellulose is below 100 μm it causes the formation of cell aggregates as observed by 
adhesion assay and low proliferation with no significant difference in cell viability as 
observed by alamar blue assay. However, the high surface area of 24.9 m2/g as obtained 
by BET and material stiffness of 23 MPa makes bacterial cellulose a cell-supporting 
material while supporting the proliferation and adhesion of human-derived placental 
mesenchymal stem cells while presenting no toxicity towards the cells. In the next 
chapter, we will focus on how bacterial cellulose material properties supports osteogenic 














 The goal of tissue engineering is to overcome current limitations that are 
associated with the standard practice that autografts/allografts/ xenografts have in the 
restoration, maintenance, or improvement of tissue function due to an injury or disease 
[171]. The most notable are immune response complications, disease transmission 
associated with the implant, and increase morbidity that is associated prolonged operation 
hours [172]. The need for biocompatible materials that can be used as cell scaffolds 
which support and guide the formation of new tissue using an individual’s own cells has 
gained enormous interest for treating bone defects that are inherently difficult to repair 
with being the second most transplanted tissue in the world [173, 174].  
An ideal scaffold is used as a template to support neo-tissues, enhance cell 
interaction and support cellular activities without any toxic effects at the site of 
implantation [47, 175]. In addition, scaffolds should have specific properties like high 
surface area and high pore interconnectivity, while maintaining the mechanical properties 
required for the selected applications [176]. The advances in scaffolds for bone tissue 
engineering introduces us to different natural and synthetic biological materials. 
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 Titanium-based scaffolds have been used to treat calvarial defects in patients and 
distal tibia and fibula fractures. These scaffolds have limited prospects due to their non- 
biodegradable nature and brittleness along with other scaffolds like hydroxyapatite and 
tantalum-based scaffolds [47, 176]. Ceramic scaffolds have been used for its 
osteoconductive properties due to similar composition to native bone mineral content but 
has limited applications due to its brittle structure and low mechanical properties. The 
application of bioactive glass has already been adapted in maxillofacial surgery, spinal 
fusion and clinical prosthesis, yet properties like brittleness, potential risk for release of 
toxic metal ions and a challenge to tune resorption rate limits its sue for clinical 
applications [172, 174, 177]. Since, the aim of native tissue is to resorb and replace 
implanted biological constructs that not only offer biodegradability but also allow 
regrowth of cells, natural polymers have been widely studied for bone tissue engineering. 
The scaffolds for bone tissue engineering must be gel-like/porous, osteoconductive 
and/or osteoinductive, biocompatible and support mineralization.  
In this study, we have demonstrated the osteogenic differentiation of human 
placental mesenchymal stem cells in vitro (hPMSCs). hPMSCs have fibroblastic 
morphology and possess multilineage differentiation capacities which include 
osteogenesis, chondrogenesis, adipogenesis, neurogenesis, and endothelialization[178, 
179]. hPMSCs are fetal-stage stem cells that have been extensively used for cartilage 
repair[180], neurogenesis[181], adipogenic differentiation[182], hepatogenic 
differentiation[183, 184], treating pancreatic disease[183, 185, 186], and treating bone 
disease and tumor growth[183, 187, 188].   
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In order to further enhance osteogenic property, I have developed Bacterial 
Cellulose (BC) scaffolds to promote cellular activities and support the differentiation of 
hPMSCs into the osteogenic lineage for bone tissue engineering applications. BC is a 
natural nanoscale polysaccharide material that is the secretion of the bacterium 
Gluconacetobacter hansenii [133] in this study. The molecular formula of BC is 
(C6H10O5)n , having a β-1,4 linkage between two glucose molecules [117]. BC has a fiber 
diameter of 20-40nm with interconnected pores and a high-water holding capacity[133]. 
BC serves as a competitive candidate in the field of bone tissue engineering due to its 
distinct chemical purity, ultrafine nanoscale structure and is an attractive alternative to 
collagen fibers due to its high tensile strength and moldability [104]. Further, high aspect 
ratio and reticulated structure has contributed to the excellent mechanical properties of 
BC. Depending on the source of carbon and method of production of BC it’s Young’s 
modulus can range from 3 MPa to 4 GPa [47]. For example, nanocomposites produced by 
Pickering emulsion method using BC showed a Young’s modulus between 3.14 and 
16.39 MPa [47, 189] while bacterial cellulose prepared from industrial wastes showed a 
Young’s modulus between 1.84 to 2.02 MPa [47, 190]. 
Along with slow degradation rates due to the glycosidic linkage necessary for 
long term support in bone tissue engineering [47] and good mechanical integrity of BC, 
we hypothesize that the polysaccharide structure of BC offering resemblance to native 
ECM [191] will support the cellular activities of hPMSCs and the organization of 
functional groups in crystalline BC will offer sites for mineralization which is an 
important property in native bone tissues. The objectives in this work were to (1) evaluate 
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the structural and physical properties of BC, (2) examine the in vitro osteogenic 
differentiation of hPMSCs and (3) to evaluate the biological activity of hPMSCs-BC 
construct. Using osteogenic media supplements on pre-seeded hPMSCs on BC, 
osteogenic differentiation was studied, and the BC-cell culture were examined for the 
extent of in-vitro mineralization.   
4.2. Osteogenesis: The Development of Bone 
 The process of bone formation either occurs by transformation of pre-existing 
mesenchymal cells to bone tissues via intramembranous ossification (flat bones in skull) 
or by differentiation of mesenchymal stem cells into cartilage that is later replaced by 
bone via endochondral ossification like in long bones, ribs and vertebrae [192, 193]. 
 The process of bone formation is as follows [192, 193]: During embryonic 
skeleton development mesenchymal cells begin to differentiate into specialized cells that 
either form capillaries while others become osteogenic cells that mature into osteoblasts 
[192]. During early stages, osteoblasts are found in clusters and secrete osteoids in the 
ossification center [192]. Osteoids are uncalcified matrix of collagen and proteoglycan 
that calcifies after the deposition of mineral salts [192, 193]. The osteoblasts then get 
trapped in the calcified matrix that matures into osteocytes. Osteocytes can help detect 
any pressure or cracks in the bone which enables them to send signals to osteoclasts that 
help dissolve the bone. While the osteoblasts mature to osteocytes, old osteoblasts 
acquire a flat morphology and become lining cells as they align on the surface of the 
bone. These lining cells then control the passage of calcium ions. 
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 The expression of osteogenic markers occurs as follows [194, 195]: The first 
stage of bone regeneration is proliferation that takes place after the cell seeding. The cells 
then start to differentiate into osteoprogenitor cells in the first two weeks of cell seeding 
with an increase in the expression of alkaline phosphatase and RUNX-2 which are early 
markers during differentiation. Followed by the expression of these markers, the next two 
week shows an increase in the expression of osteocalcin that is expressed by osteoblasts 
and marks the process of osteogenic differentiation. Lastly, biomineralization and  




Figure 23. Expression of Osteogenic Markers During Bone Regeneration 
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4.3. Materials and Methods 
4.3.1. Bacterial Cellulose Mineralization 
 The BC pellicle was soaked in 50mM calcium chloride solution for one hour, 
washed with sterile water and then soaked in 30mM phosphoric acid solution (pH 7.0) for 
24 hours in a water bath maintained at 37֯ C to obtain a Calcium to phosphorus ratio of 
1.67. The above procedure was followed to obtain calcium to phosphorus ratio of 1.33 by 
using 60mM calcium chloride solution and 45mM phosphoric acid solution. The BC 
pellicle was washed with ethanol and kept under UV for 15 min. The pellicle was then 
washed with sterile water and placed in hPMSCs medium for 24 hours prior to cell 
culture. 
4.3.2. Characterization of Mineralized Bacterial Cellulose 
 Fiber diameter and morphology of mineralized BC were characterized using a 
Carl Zeiss Auriga-BU FIB FESEM Microscope (FESEM) (Carl Zeiss, Jena, Germany). 
Samples were first mounted on 1 cm2 stubs using carbon tape sputter-coated with ~3nm 
gold-palladium using argon plasma Denton Vacuum Inc. Desk II Sputter Coater to avoid 
sample charging. Images were taken at a working distance of 7 mm and a gun 
accelerating voltage of 3 kV.  
Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectra was 
used to understand the chemical integrity of mineralized BC using Varian 670 IR (Paulo 
Alto, CA). All spectra were recorded in a wavenumber range of 4000–650 cm−1 with a 




4.3.3. Osteogenic Differentiation of Human-Derived Placental Mesenchymal Stem 
Cells (hPMSCs) on Bacterial Cellulose Scaffolds 
 Human-derived PMSCs were cultured in osteogenic medium consisting of low-
glucose Dulbecco’s modified Eagle medium (DMEM) with 10% FBS, 1% Pen/Strep 
(HyClone, GE Healthcare Life Sciences, South Logan, Utah) and osteogenic supplements 
(Sigma Aldrich: 100 nM dexamethasone, 10 mM β-glycerophosphate and 50 mg mL−1 
ascorbicacid-2-phosphate). Cells were cultured in growth medium as well as on tissue 
culture plate (TCP) as controls as stated in the experiments. The cells were cultured for a 
period of 28 days and the culture medium was changed every alternate day. The growth 
medium was replaced with differentiation medium after 48 hours for all in vitro 
osteogenic differentiation assays.   
For all assays never-dried BC pellicles were seeded into wells of a 24-well tissue 
culture plates. BC samples were washed with 70 % ethanol followed by de- ionized (DI) 
water three times, sterilized under ultraviolet light for 2-4 hours and incubated in growth 




Figure 24. Schematic of in vitro Culture of Human-Derived Placental Mesenchymal Stem 
Cells on Bacterial Cellulose Scaffolds Towards Osteogenic Lineage 
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4.3.3.1. Alkaline Phosphatase Activity 
 Alkaline Phosphatase activity (ALP) was extracted from cell-BC construct and its 
activity was examined for the time points day 1 (post 24 hours), day 3 and day 14 using 
1-Step™ PNPP (p-nitrophenyl phosphate disodium salt) Substrate Solution (37621- 
ThermoFisher Scientific) and used according to the manufacturer’s guidance. Briefly, BC 
samples were homogenized in 0.2% Triton X-100, transferred to a 1 mL Eppendorf tube 
and incubated at 37 ֯C for 20 minutes. Similarly, cells seeded on TCP were lysed in 0.2% 
Triton X-100 and collected after 20 min of incubation. 50 μl of BC and TCP solution 
were added to 96-well plate and 100 μl of PNPP solution was added to each well. The 
plate was incubated for 15-30 minutes until the color in each well changed to a yellow-
color product. 50 μl of 2N sodium hydroxide was added to each well to stop the reaction. 
The absorbance was read at 405nm using a microplate reader (SpectraMax M5, 
Molecular Devices, Sunnyvale, CA, USA). 
4.3.3.2. Alizarin Red Assay 
 Bacterial cellulose-hPMSCs were cultured in 24 well plate and rinsed in PBS and 
fixed in 4% paraformaldehyde for 20 min. The samples were then rinsed in distilled water 
and 500 μl of 40mM alizarin red stain (pH 4.1) was added. The samples were incubated 
for 15-20 min with gentle shaking. The dye was removed, and samples were soaked in 
distilled water for 24 hours to remove any excess dye.
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4.3.3.3. Energy-Dispersive X-ray Spectroscopy 
 hPMSCs were cultured on BC samples and TCP for Day 14, 21 and 28 for the 
calcium content in growth and differentiation medium. The samples for calcium analysis 
were examined using to SEM and Energy-Dispersive X-ray Spectroscopy (EDS). The 
samples are placed in the fixative solution for SEM and EDS analysis that consisted of 
25% of 0.4M Cacodylate buffer, 12.5% of 16% formaldehyde, 10% of 25% 
glutaraldehyde and DI water. The samples are placed in this fix overnight, washed using 
autoclaved water (3X) and air-dried overnight before imaging. For imaging, the samples 
were mounted on 1 cm2 stubs using carbon tape sputter-coated with ~5nm gold-
palladium using argon plasma Denton Vacuum Inc. Desk II Sputter Coater to avoid 
sample charging. Surface Characteristics of BC and TCP samples were observed using 
Carl Zeiss Auriga-BU FIB FESEM Microscope (FESEM) (Carl Zeiss, Jena, Germany). 
For each image obtained using SEM, calcium content was quantified using EDS. 5 
different readings on the samples were obtained at varied locations and the average of 
these reading were plotted for individual sample. The analysis was performed using the 
HyperMap tool at 3000 x magnification and an accelerating voltage of 10kV. 
4.3.3.4. Total Collagen Content 
 The total collagen content was measured using the colorimetric hydroxyproline 
quantification method (K218-100- BioVision Incorporated, Milpitas, California). Briefly, 
constructs were washed with deionized water three times for 5 min each and then 
homogenized with a deionized water in a 1 mL scintillation vials and equal amount of 
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concentrated HCl was added. The samples were hydrolyzed at 60֯C overnight to extract 
collagen. 4 mg of charcoal was added to each vial and centrifuged 
at 10000 X g for 3 min to remove the precipitate and activated charcoal. 20 μl of each 
sample was added to a 96-well plate and evaporated to dryness at 60֯C for 20-30 minutes. 
The reagents were prepared as per the manufacturer’s instructions. Once the samples 
have been dried, 100μl of Chloramine T was added to each well and incubated for 5 min 
followed by 100 μl of DMAB reagent and incubated for 90 min at 60֯C. The plate was 
then measured at absorbance at 560 nm in a microplate. 
4.3.3.5. Gene Expression Study 
 hPMSCs for osteogenic differentiation were cultured on BC and TCP for Day 14, 
21 and 28. The expression levels of osteogenic marker genes were determined by 
quantitative real-time PCR. Total RNA was isolated from differentiated cells using the 
TRIZOL reagent (Invitrogen, Carlsbad, CA). The RNA was subjected to a wash using 
RNeasy MinElute Cleanup Kit from Qiagen. An equivalent amount of each RNA sample 
was converted into cDNA using the QuantiTect Reverse Transcription Kit from Qiagen. 
Next the cDNA was subjected to gene-specific PCR for RUNX-2 and OCN (osteocalcin). 
Details of primers are listed in Table 1. PCR amplification was performed on a real-time 
PCR machine (ABI 7500, USA) using a kit (Power Syber Green master mix -Thermo 
Fisher Scientific) with GAPDH (glyceraldehyde-3-phosphate dehydrogenase) for 




Table 10. Osteogenic Gene Expression  




















4.3.4. Statistical Analysis 
 Student’s t test was used to determine whether the differences within the same 
time point were significant. Two-way ANOVA were applied to all other comparisons. All 
values were reported as mean ± SD. A value of P < 0.05 was considered significant. 
Duplicates per group were used unless specified otherwise.
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4.4. Results and Discussion 
4.4.1. Characterization on Mineralized Bacterial Cellulose 
 We characterized the morphology and structure of our BC nanocomposites using 
SEM and FTIR spectroscopy shown in FIGURE 25 AND 26. SEM analysis of 
composites of mineralized BC resulted in a pellicle that is completely encased in 
hydroxyapatite crystals with little of the fibrous nanocellulose filaments observed 
(FIGURE 25 C and D).  In the chemical precipitations procedure that we used, the HA 
crystals that deposited on the BC fibers formed in agglomerates and had a flake-like 
morphology (FIGURE 25 D, red arrow). We confirmed the presence of HA deposition on 
the BC nanofibers by FTIR analysis.  The presence of HA on the BC was confirmed by 
the reduction in the intensity around 3340 cm-1, a band assigned to hydroxyl groups of 
the cellulose polymer demonstrated that the HA are interacting with this group. The FTIR 
bands further observed at 1024 and 960 cm-1 were attributed to vibrational modes of 
phosphate ions. the weak intensities around 871 and 1400 cm-1 suggests the absorption 
of CO2 from air. Similar results in terms of morphology and chemical structure of 




Figure 25. Bacterial Cellulose Characterization Showing (A): Dry Bacterial Cellulose 
Before Mineralization, (B): Dry Bacterial Cellulose After Mineralization, (C-D): 




Figure 26. FTIR of Neat and Mineralized Bacterial Cellulose 
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4.4.2. Osteogenic Differentiation of Human-Derived Mesenchymal Stem Cells on 
Bacterial Cellulose Scaffolds 
4.4.2.1. Alkaline Phosphatase Activity 
 ALP activity in hPMSCs on BC scaffolds and TCP was determined on day 1, day 
3 and day 14 after induction in osteogenic medium and growth medium as shown in 
FIGURE 27. ALP activity on BC and TCP increased over a period of two weeks. The 
ALP activity in the cell/BC construct was significantly higher in differentiated cells as 
compared to growth medium. The ALP activity between the time points day 1 and day 14 
(p<0.05) and day 3 and day 14 (p<0.05) in the cell/BC construct showed a significant 
difference. In the differentiated cells on BC and TCP, a significant difference was 




Figure 27. Alkaline Phosphatase Activity of hPMSCs Cultured Bacterial Cellulose (BC) 
and Tissue Culture Plate (TCP-control) In Growth (control) and Differentiation Media 
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4.4.2.2. Alizarin Red Assay 
 To study the deposition of calcium on bacterial cellulose alizarin red staining 
assay was performed. Never-dried BC in growth media did not show any red stain on 
Day 14, 21 and 28. Never-dried BC in differentiation media showed an increase in the 
red coloration with minimum on Day 14 (FIGURE 28D) to bright red on Day 28  




Figure 28. Alizarin Red Staining on hPMSCs Cultured Bacterial Cellulose Scaffold: (A-
C): In Growth Media on Day 14, 21 and 28 Respectively; (D-F): In Differentiation Media 
on Day 14, 21 and 28 Respectively
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4.4.2.3. Energy-Dispersive X-ray Spectroscopy 
EDS was used to determine the calcium composition on BC scaffolds and TCP in 
osteogenic and growth medium. Graph shows that amount of calcium increased on both 
BC and TCP from day 14 through day 28 of the study (FIGURE 29 and 30). EDS of BC 
scaffolds shows significant difference over a period of 28 days in the amount of calcium 
as compared to cell/BC construct subjected to growth medium. A similar result is 
observed on TCP with high content of calcium in osteogenic medium as compared to 
growth medium. Further, BC scaffolds shows a significant increase in mineralization as 
compared to TCP (FIGURE 31). The electron microscope image of cell/BC (FIGURE 32 
and 33) with and without mineralization with the amount of calcium as seen by EDS 
(FIGURE 32 and 33) over a period of 28 days confirmed that cells on bacterial cellulose 




Figure 29. Energy-Dispersive X-ray Spectroscopy of hPMSCs on Bacterial Cellulose 




Figure 30.  Energy-Dispersive X-ray Spectroscopy of hPMSCs on Tissue Culture Plate 





Figure 31. Energy-Dispersive X-ray Spectroscopy of hPMSCs on Bacterial Cellulose and 





Figure 32. Scanning Electron Microscope Image and Energy-Dispersive X-ray 
Spectroscopy Showing Elemental Analysis of Calcium; (A-B): Day 14 hPMSCs Cultured 
on Bacterial Cellulose in Growth Media, (C-D): Day 28 hPMSCs Cultured on Bacterial 




Figure 33. Scanning Electron Microscope Image and Energy-Dispersive X-ray 
Spectroscopy Showing Elemental Analysis of Calcium; (A-B): Day 14 hPMSCs Cultured 
on Bacterial Cellulose in Differentiation Media, (C-D): Day 28 hPMSCs Cultured on 






4.4.2.4. Total Collagen Content 
 Total collagen content assay shows no difference between differentiated and non-
differentiated group on neat never-dried BC scaffolds as observed in FIGURE 34. This 
suggests similar amount of collagen was produced in growth and differentiation medium. 
A significant difference was observed between the differentiated groups at 1- week and  




Figure 34. Total Collagen Content of hPMSCs Cultured on Bacterial Cellulose in Growth 
(control) and Differentiation Media 
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4.4.2.5. Gene Expression: Osteogenic Differentiation 
 Expression levels associated with osteogenic differentiation of mRNA levels were 
examined using PCR at day 14, 21 and 28 (FIGURE 35). Expression of two transcription 
factors related to osteogenic differentiation, osteocalcin (OCN) and RUNX2, were 
studied in the cells cultured on neat never-dried BC scaffolds. The expression of early 
marker RUNX2 was higher on day 14 as compared to day 28, yet there was no significant 
difference between time points for RUNX2. The high expression of RUNX2 in the early 
stages of differentiation have also been reported by several studies [198, 199]. The 
expression of non-collagenous bone ECM proteins OCN showed significant increase in 
its expression over a period of 28 days (p<0.05). This data suggests that the cell-BC 





Figure 35. Gene Expression of hPMSCs on Bacterial Cellulose Towards Osteogenic 




 In this study, we have explored the material properties of bacterial cellulose 
which enabled its application as a potential scaffold for bone tissue engineering. The free 
hydroxyl groups which is a characteristic of bacterial cellulose in its never-dried served 
as a site for the initiation of mineralization as shown by chemical precipitation of calcium 
chloride and phosphoric acid. The scanning electron microscope image and FTIR 
spectrum confirmed the presence of crystals formed due to the deposition of 
hydroxyapatite. The crystals formed as agglomerates while covering the entire surface of 
the never-dried bacterial cellulose pellicle. One important observation found in the FTIR 
spectrum was the reduction in the hydroxyl peaks of the hydroxyapatite spectrum as 
compared to neat never-dried bacterial cellulose. This reduction in hydroxyl peak formed 
the most important basis of this study as the functional groups in neat never-dried 
bacterial cellulose (hydroxyl groups -hydrophilic nature and neutral charge [200]) was 
able to support the mineralization process of hydroxyapatite. This was further applied to 
the process of bone regeneration by studying the differentiation of human-derived 
placental mesenchymal stem cells and the extent of in vitro mineralization. Alkaline 
phosphatase acitivity was studied as an early marker for osteogenic differentiation. An 
increase in the enzyme activity to measure alkaline phosphatase activity was observed 
over a period of 14 days in differentiation medium as compared to bacterial cellulose in 
growth medium and tissue culture plate in growth and differentiation medium. The 
deposition of calcium was analyzed by alizarin red assay which showed an increase in the 
deposition of calcium over a period of 28 days as seen by the increase in the intensity of 
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the red color which denotes the presence of calcium. There was no calcium present on 
hPMSCs-bacterial culture in differentiation medium. To quantify the amount of calcium 
present on the material, energy-dispersive x-ray spectroscopy was studied. A significant 
increase in the calcium weight percentage was observed in both hPMSCs-bacterial 
cellulose and hPMSCs-tissue culture plate culture in differentiation media over a period 
of 28 days and a significant increase in calcium weight percentage in hPMSCs-bacterial 
cellulose in differentiation medium on day 21 and 28 as compared to hPMSCs-tissue 
culture plate in differentiation medium. Further, bacterial cellulose morphological 
characterization shows random orientation of cellulose fibers which accounts for 
improved cell proliferation on day 5 as compared to day 1. This is because bacterial 
cellulose has a twisted fibrous morphology [154] which allows for efficient cell seeding 
of hPMSCs. Due to its random orientation which improves cellular functions, high 
osteogenic differentiation is observed as compared to tissue culture plate [194]. A 
significant difference in the total collagen content is observed over a period of 4 weeks in 
the differentiation media, although it is unclear how the collagen has deposited on the 
material based on the orientation of the fibers. Nevertheless, the deposition of collagen 
and cell differentiation on bacterial cellulose might be due to its fiber orientation as 
observed in the literature [194].  
The pore size of bacterial cellulose as obtained by BET was 8.9094 nm. Since, the 
pore size of bacterial cellulose is below 100 μm it causes the formation of cell aggregates 
as observed by adhesion assay and low proliferation with no significant difference in cell 
viability as observed by alamar blue assay. The material was still able to support the 
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growth of cells due to its hydrophilicity and fibrous structure that is found in the native 
extracellular matrix. Further, it was observed that there was no significant difference in 
the alkaline phosphatase activity for a period of 14 days in differentiation media, but a 
significant difference between growth and differentiation media for bacterial cellulose 
scaffolds. Thus, low pore size causes delayed activity of alkaline phosphatase which is an 
early osteogenic marker. Another observation was obtained from the energy-dispersive x-
ray spectroscopy which did show mineralization over a period of 28 days. This is due to 
the presence of hydroxyl groups (hydrophilic nature and neutral charge [200]) that allows 
as sites for the improved mineralization during the osteogenic differentiation with a 
significant difference over a period of 28 days. This further showed an upregulation of 
osteogenic gene expression. Low pore size is a limitation of bacterial cellulose, but its 
structural property and morphology benefits the growth of hPMSCs while supporting 
osteogenic differentiation. 
In conclusion, bacterial cellulose is a promising biomaterial with simple 
fermentation protocol and ease of sterilization as it can with stand high temperatures 
without causing any change in morphological and structural properties. The chemical 
composition and physical structure of bacterial cellulose used in this study as a cell-
supporting matrix meets the basic requirements of a tissue engineering scaffold like 
similar structure to native extracellular matrix [191], biocompatibility, high surface area 
and no toxicity. This is suitable for cell growth as well as differentiation. Further, 
properties like easy moldability, antimicrobial effect, hydrophilicity and nanoporosity 
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5.1. Production of Bacterial Cellulose Foam 
 The tu´ngara frog of tropical America, Engystomops pustulosus (formerly 
Physalaemus pustulosus), release eggs along with foam precursor fluids which results in 
a foaming nest for their embryos to develop into tadpoles [201]. The foam formation is 
facilitated by the reduction in surface tension of the air-liquid interface[202]. These 
tropical and sub-tropical frogs produce their nests that are seen either floating on the 
surface of water, suspended in vegetation, on tree branches or found in enclosed spaces 
like underground burrows [201, 203]. These foam nests are composed of dilute solutions 
of proteins and carbohydrates that are one of the rare surfactants found in nature [203]. 
The foam nests are anti-bacterial and anti-fungal and can resist dehydration and microbial 
degradation [201, 203]. With the foam’s natural ability to protect in its embryonic stages 
against harsh environmental conditions, its applications in the medical field can range 
from wound healing to surgical matrices for tissue engineering [204].  
 The túngara or mud-puddle frog form these nests that comprises of 90% air with 
1-2mg/ml of proteins and complex carbohydrates in the aqueous phase [203]. The  
biochemical analysis shows that the foam is composed of a mixture of proteins called 
ranaspumins named from ranaspumins-1 to ranaspumins-6 in the 11-25 kDa size range. 
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Ranaspumin-3 to ranaspumin-6 are from the lectin family (carbohydrate-recognizing 
protein), ranaspumin-1 represents the cystatins (inhibits protein-degrading protease 
Enzymes) and ranaspumin-2 is a protein that is responsible for reducing surface tensions 
(at 1-10 μg/ml concentration [203]) and producing foams [204].  
 Ranaspumin-2 has an amino sequence with a highly-charged hydrophilic C-
terminus coupled with a significantly non-polar N-terminal sequence that explains the 
amphiphilic (hydrophilic and hydrophobic) characteristics of common detergents [203]. 
A study explained that the natural foam showed an air-interface layer which can be 
applied towards producing bacterial cellulose foam as the synthesis of cellulose also takes 
place at the air-medium interface during bacterial culture [203, 205]. The advantages of 
ranaspumin-2 over other surfactants like lipopeptides and surfactin are that it causes no 
disruptive effect to the biological membranes when incorporated into surfaces and it can 
actively form foam when used at low concentrations [206]. The only disadvantage known 
about ranaspumin-2 is that unlike its ability to remain stable in its natural state (natural 
frog foam) it collapses in few minutes under laboratory conditions [206]. This suggests 
that the cocktail of proteins present in the natural foam is required for the foam to provide 
long term mechanical stability and resistance to dehydration [206]. In this work, we aim 
at producing foam structures of bacterial cellulose using the surfactant properties of 
ranaspumin-2 for improved morphology and achieving a three-dimensional structure of 
bacterial cellulose. This will enable us to control the porosity, structural arrangement of 
the cellulose fibers while improving its pellicle size as the bacterial cellulose fermented 
using static culture only produces a flat sheet up to a thickness of ~0.2μm. 
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5.1.1. Experimental Section 
5.1.1.1. Plasmid Isolation Protocol:  
1. Inoculate 5 ml LB medium with kanamycin culture overnight at 37 degree with 
shaking. 
2. Harvest bacteria by centrifuge at 3000 rpm for 5 minutes, remove supernatant and 
keep the pellet. 
3. Add one vial of RNase A to Solution A1 in the miniprep kit by Apex. 
4. Resuspend the pellet in 250 μl Solution A1 by vortexing or pipetting and transfer 
the mixture to a clean microcentrifuge tube. 
5. Add 250 μl Solution A2, mix gently by inverting 7-8 times at room temperature. 
6. Add 350 μl Solution A3, mix immediately by inverting tube 7-8 times at room 
temperature. 
7. Spin down at 12000 rpm for 10 min. transfer supernatant to a spin column and 
discard pellet. 
8. Centrifuge spin column at 12000 rpm for 1 min. Discard flow through. 
9. Wash spin column with DI water, centrifuge at 12000 rpm for 1 min. discard flow 
through. 
10. Centrifuge at 12000 rpm for an additional 1 min to remove residual wash buffer. 
11. Place spin column in a clean 1.5ml microcentrifuge tube. Add 50-100 μl Solution 
AE to the center of the membrane. Let stand for 2 min. Centrifuge at 12000 rpm 
for 1 min to collect eluted DNA.  
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12. Measure absorbance using Nanodrop. 260/280 ratio: less than 1.8 = protein and 
more than 2 = RNA.  
5.1.1.2. Protein Expression in BL21 (DE3) Bacteria: 
 Transform the expression rsn-2 plasmid collected in the PLASMID ISOLATION 
PROTOCOL into BL21 (DE3). Plate on LB-kanamycin selection plates and 
incubate at 25֯ C, 30֯ C and 37֯C for 3-4 days and check the formation of colonies.  
 Resuspend a single colony from each plate obtained at different temperatures in 
10 ml LB culture with kanamycin antibiotic. Freeze the remaining colonies at -80֯ 
C for future use. 
 Incubate at 37֯C with shaking until OD600 reached 0.4-0.8. 
 Induce with 4 or 40 μl of a 100 mM stock of IPTG (final concentration of 40 or 
400 μM) and induce for 3 to 5 hours at 37֯C or 1mM for 4 hours under agitation at 
30 ֯C 
 Check for expression under black light to observe a blue-green fluorescence. 
Compare with a control flask with only media.  
 Proceed by spinning down the solution and freezing the cell paste only at -80֯ C. 




5.1.1.3. Lysis and Sonication of the Bacteria: 
 Make lysis buffer 1/20 or 1/50 the volume of the bacterial culture: lysozyme 
1mg/ml, (NaH2PO4+NaHPO4) 50nM, NaCl 300mM, Imidazole 10mM and 
water. Adjust pH to 8 using NaOH. 
 Add the volume of lysis buffer to the frozen cell paste post IPTG induction. 
 Incubate the suspension at room temperature for 20-30 minutes, or until the 
suspension becomes turbid and viscous due to the release of the bacteria’s 
genomic DNA. 
 Freeze-thaw 6 cycle in liquid nitrogen and water at 37֯C to eliminate the extreme 
turbidity of the sample.  
 Pass the solution through a 1ml syringe to help with the process of reducing 
turbidity. This step helps to shear the DNA. 
 Spin the solution for 5 minutes at full speed. Proceed by collecting the 
supernatant. The protein collected in the supernatant can be frozen till further use.  
5.1.1.4. Spin Purification of His-Tagged Proteins: 
 After collecting the supernatant from the LYSIS and SONICATION of the 
BACTERIA steps, prepare a set of buffers needed to protein purification using 
nickel-charged nitriloacetic acid spin columns. 
 Make the equilibration buffer (50mM (NaH2PO4+Na2HPO4), 300mM NaCl, 
10mM Imidazole, pH 8 with NaOH), wash buffer (50mM 
(NaH2PO4+Na2HPO4), 300mM NaCl, 20mM Imidazole, pH 8 with NaOH) and 
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elution buffer (50mM (NaH2PO4+Na2HPO4), 300mM NaCl, 250mM Imidazole, 
pH 8 with NaOH). 
 SAMPLE PREP: Mix equal volumes of both protein extract (supernatant: 
Lysis+cell paste) and equilibration buffer.  
 First, remove the bottom tab from the spin column and place the column in a 
centrifuge tube. Centrifuge the column at 700 g for 2 minutes to remove storage 
buffer.  
 Next, add the equilibration buffer to HisPur Ni-NTA spin column and adjust the 
volume to equal to 2 resin-bed volumes. Shake gently to allow the buffer to enter 
the resin bed.  
 Centrifuge column at 700 g for 2 minutes to remove buffer. 
 Place the bottom plug in the column and the prepared sample. Mix this set-up on 
an orbital shaker or end-over-end mixer for 24 hours at room temperature. Add 
10-50μl of 0.1M sodium azide to avoid proteolytic cleavage of proteins.  
 Remove the bottom plug and centrifuge the column at 700 g for 2 minutes. 
Collect the flow-through in a centrifuge tube. 
 Wash the column with wash buffer with two resin-bed volumes and centrifuge at 
700 g for 2 minutes and collect the flow-through. Repeat this process two more 
times. 
 Elute the protein from the resin by adding on resin-bed volume of Elution buffer 
and centrifuge at 200 g for 2 minutes. Repeat this step two more times.  
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 Measure the protein absorbance at 280nm to calculate the yield. The protein can 
also be analyzed by SDS-PAGE analysis.   
5.1.2. Results 
 Ranaspumin-2 plasmid were plated at different temperatures on LB-kanamycin 
plates at 25֯C, 30֯C and 37֯C (from left to right indicated by yellow arrows) before 
resuspending the colony on LB-kanamycin media. The figure shows the expression of 
ranaspumin-2 post IPTG induction. A blue-green fluorescence was observed in the 
samples as compared to control (LB-kanamycin media-red arrow) as observed in 
FIGURE 36A. The protein was purified with HisPur Ni-NTA spin column and the foam 





Figure 36. (A): Expression of Ranaspumin-2 After IPTG Induction; (B): Ranaspumin-2 
Foam Post Purification from BL21(DE3) Bacteria
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5.2. Importance of Hydrophilicity During Osteogenic Differentiation 
5.2.1. Experimental Section 
The difference in the extent of osteogenic differentiation and to assess the 
importance of hydrophilicity during the process of mineralization in bone regeneration 
two modified forms of bacterial cellulose were studied. The air-dried and lyophilized 
bacterial cellulose have been investigated for its biocompatibility as compared to neat 
never-dried bacterial cellulose. 
5.2.1.1. Simulated Body Fluid Study 
To evaluate the difference in bone bioactivity and the extent of osteogenic apatite 
formation, modified bacterial cellulose and neat never-dried bacterial cellulose were 
submerged in simulated body fluid. Simulated body fluid is an ionic solution composed 
of ion concentrations that are found in the human blood plasma. The solution was 
replaced every day for a period of 7 days. The materials were characterized using 
scanning electron microscope and energy-dispersive x-ray spectroscopy as explained in 
chapter 3. 
5.2.1.2. Expression of Osteogenic Marker: Alkaline Phosphatase 
hPMSCs were cultured on modified bacterial cellulose and neat never-dried 
bacterial cellulose to study the expression of alkaline phosphatase activity for a period of 




The extent of mineralized layer on bacterial cellulose simulated body fluid study 
was performed. A high percentage of mineralized layer was found on neat never-dried 
bacterial cellulose with a significant increase in the calcium weight percentage as 
compared to dry bacterial cellulose and lyophilized bacterial cellulose (FIGURE 37 A-C). 
Further, an increase in alkaline phosphatase activity was observed on neat never-dried 
bacterial cellulose as compared to dry bacterial cellulose and lyophilized bacterial 
cellulose (FIGURE 37-top right). With the presence of functional groups in bacterial 
cellulose in its never-dried state the material offers sites for the formation of an apatite 
layer as compared to modified bacterial cellulose where there is less availability of 
hydroxyl groups. Similarly, bacterial cellulose with hydroxyl groups up-regulated the 
osteogenic expression of early marker alkaline phosphatase as compared to modified 






Figure 37. (A-C): Scanning Electron Microscope Image of Simulated Body Fluid Study 
on Dry BC, Lyophilized BC and Neat Never-Dried BC Respectively, Graph Showing the 
Calcium Weight Percentage Obtained by Energy-Dispersive X-ray Spectroscopy (bottom 
left), Graph Showing Alkaline Phosphatase Activity on Modified Bacterial Cellulose and 




 In the biomedical field, bacterial cellulose has been applied to a wide range of 
applications for ideal structure and biocompatibility. In this work, we have presented 
unique properties of bacterial cellulose that facilitated its application to study bone tissue 
engineering.  
 Nanoscale morphology of bacterial cellulose presented with improved surface 
area which supported the growth of human-derived placental stem cells. The high surface 
area and nano pore structure can be applied in future to develop implants and prosthetic 
devices as it improves protein adsorption while reducing in bacterial infections and 
implant failure [207]. Further the hypothesis to present cells with nanoscale feature is that 
cells in its native state itself has many nanostructures like filipodia, cytoskeleton and 
membrane proteins [208]. Application of nanomaterials can help the cells proliferate in 
its more natural environment and enable scientists take a step closer to mimic complex 
human tissues [208].   
 The hydrophilicity of bacterial cellulose in its never-dried state also serves for 
many applications in tissue engineering as the presence of three accessible hydroxyl 
groups per repeat unit favors for modifications (like introducing ionic charge to facilitate 
cell attachment) and formation of composites [209]. It has been used to treat skin burns 
because an increase in re-epithelization was found when the wound healing process is 
supported in a moist environment [210]. We, therefore utilized this property of bacterial 
cellulose to study its feasibility to form hydroxyapatite crystals as a high concentration of 
hydroxyl groups promotes the precipitation formation of particles and the chemical 
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composition of hydroxyapatite are native to the natural bone which is the main objective 
of this study [211]. With never-dried bacterial cellulose able to form crystals of 
hydroxyapatite, human-derived placental stem cells (possess multilineage differentiation 
and is easy to isolate, expand without any ethical issues[212]) were cultured and 
differentiated towards osteogenic lineage on bacterial cellulose to examine if similar 
results are obtained. The calcium weight percentage increased over a period of 28 days 
and the material was found to be completely mineralized by the end of 28 days. The 
presence of hydroxyl groups served as a template for the cells to express its cellular 
functions in its most native state while expressing osteogenic markers. Further, low 
apatite layer was found when air-dried and lyophilized bacterial samples were studied as 
compared to never-dried bacterial cellulose.  
 Topographic guidance influences cell shape and cellular functions. The cells will 
further deposit extracellular matrix based on the material’s morphological features. The 
use of bacteria in this study has a limitation in being able to control the topography as it 
can only produce cellulose at the air-liquid interface [123] in the form of a flat sheet. 
Since cells interact with the extracellular matrix, organize the matrix and generate 
patterns essential for tissue functions it is important to study different methods by which 
one can control the shape and size of bacterial cellulose that will help recreate tissue-
specific geometry. In this study, we have shown a method to control the morphology and 
topography of bacterial cellulose using the frog surfactant protein- ranaspumin-2. We 
found that the foam was not stable for longer period as in nature there is a complex of 6 
different types of materials that help stabilize the foam [204]. Foam stabilizers and 
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complex carbohydrates are therefore needed to mimic the native foam to achieve stability 
of the ranasmpumin-2 foam to allow for bacteria to deposit cellulose along the structure 
of foam.  
 In conclusion, bacterial cellulose has a three-dimensional nanoscale structure 
which presents as a biocompatible material for bone tissue engineering. Its ability to 
interact with different materials like polymers, metals and ceramics offers future 
improvements in mechanical properties and surface modifications while supporting the 
fabrication of bacterial cellulose-based composites for not only the biomedical field but 
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